BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hätscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009;361:2033-45. [PMID: 19890111 DOI: 10.1056/NEJMoa0907206] [Cited by in Crossref: 948] [Cited by in F6Publishing: 538] [Article Influence: 72.9] [Reference Citation Analysis]
Number Citing Articles
1 Tian T, Wang Z, Zhang J. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies. Oxid Med Cell Longev 2017;2017:4535194. [PMID: 28744337 DOI: 10.1155/2017/4535194] [Cited by in Crossref: 144] [Cited by in F6Publishing: 139] [Article Influence: 28.8] [Reference Citation Analysis]
2 Buongusto F, Bernardazzi C, Yoshimoto AN, Nanini HF, Coutinho RL, Carneiro AJV, Castelo-Branco MT, de Souza HS. Disruption of the Hedgehog signaling pathway in inflammatory bowel disease fosters chronic intestinal inflammation. Clin Exp Med 2017;17:351-69. [PMID: 27655445 DOI: 10.1007/s10238-016-0434-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Su W, Yu Y, Xu X, Wang XQ, Huang JB, Xu CD, Xiao Y. Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases. World J Gastroenterol 2021; 27(1): 92-106 [PMID: 33505153 DOI: 10.3748/wjg.v27.i1.92] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Küçük C, Wei L, You H. Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy. Front Oncol 2020;10:1276. [PMID: 32850389 DOI: 10.3389/fonc.2020.01276] [Reference Citation Analysis]
5 Pope JL, Yang Y, Newsome RC, Sun W, Sun X, Ukhanova M, Neu J, Issa JP, Mai V, Jobin C. Microbial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant Isolate. Sci Rep 2019;9:3380. [PMID: 30833613 DOI: 10.1038/s41598-019-39887-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Shouval DS, Ebens CL, Murchie R, McCann K, Rabah R, Klein C, Muise AM, Snapper SB. Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;63:e15-7. [PMID: 27336593 DOI: 10.1097/MPG.0000000000000532] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
7 Cardinale CJ, Kelsen JR, Baldassano RN, Hakonarson H. Impact of exome sequencing in inflammatory bowel disease. World J Gastroenterol 2013; 19(40): 6721-6729 [PMID: 24187447 DOI: 10.3748/wjg.v19.i40.6721] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
8 Jacobse J, Li J, Rings EHHM, Samsom JN, Goettel JA. Intestinal Regulatory T Cells as Specialized Tissue-Restricted Immune Cells in Intestinal Immune Homeostasis and Disease. Front Immunol 2021;12:716499. [PMID: 34421921 DOI: 10.3389/fimmu.2021.716499] [Reference Citation Analysis]
9 Casanova JL, Abel L. Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories. Annu Rev Pathol 2021;16:23-50. [PMID: 32289233 DOI: 10.1146/annurev-pathol-031920-101429] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
10 Cho JH, Feldman M. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med. 2015;21:730-738. [PMID: 26121193 DOI: 10.1038/nm.3897] [Cited by in Crossref: 132] [Cited by in F6Publishing: 117] [Article Influence: 18.9] [Reference Citation Analysis]
11 Ye M, Joosse ME, Liu L, Sun Y, Dong Y, Cai C, Song Z, Zhang J, Brant SR, Lazarev M, Li X. Deletion of IL-6 Exacerbates Colitis and Induces Systemic Inflammation in IL-10-Deficient Mice. J Crohns Colitis 2020;14:831-40. [PMID: 31679013 DOI: 10.1093/ecco-jcc/jjz176] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
12 Avitzur Y, Guo C, Mastropaolo LA, Bahrami E, Chen H, Zhao Z, Elkadri A, Dhillon S, Murchie R, Fattouh R. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology. 2014;146:1028-1039. [PMID: 24417819 DOI: 10.1053/j.gastro.2014.01.015] [Cited by in Crossref: 127] [Cited by in F6Publishing: 103] [Article Influence: 15.9] [Reference Citation Analysis]
13 Wekell P, Karlsson A, Berg S, Fasth A. Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome. Acta Paediatr 2016;105:1140-51. [PMID: 27426283 DOI: 10.1111/apa.13531] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
14 Ostrowski J, Paziewska A, Lazowska I, Ambrozkiewicz F, Goryca K, Kulecka M, Rawa T, Karczmarski J, Dabrowska M, Zeber-Lubecka N. Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population. Sci Rep. 2016;6:39831. [PMID: 28008999 DOI: 10.1038/srep39831] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
15 Holzinger D, Kessel C, Omenetti A, Gattorno M. From bench to bedside and back again: translational research in autoinflammation. Nat Rev Rheumatol 2015;11:573-85. [PMID: 26077920 DOI: 10.1038/nrrheum.2015.79] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
16 Moehle MS, West AB. M1 and M2 immune activation in Parkinson's Disease: Foe and ally? Neuroscience 2015;302:59-73. [PMID: 25463515 DOI: 10.1016/j.neuroscience.2014.11.018] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 11.9] [Reference Citation Analysis]
17 Brockmann L, Soukou S, Steglich B, Czarnewski P, Zhao L, Wende S, Bedke T, Ergen C, Manthey C, Agalioti T, Geffken M, Seiz O, Parigi SM, Sorini C, Geginat J, Fujio K, Jacobs T, Roesch T, Izbicki JR, Lohse AW, Flavell RA, Krebs C, Gustafsson JA, Antonson P, Roncarolo MG, Villablanca EJ, Gagliani N, Huber S. Molecular and functional heterogeneity of IL-10-producing CD4+ T cells. Nat Commun 2018;9:5457. [PMID: 30575716 DOI: 10.1038/s41467-018-07581-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
18 Dovrolis N, Filidou E, Kolios G. Systems biology in inflammatory bowel diseases: on the way to precision medicine. Ann Gastroenterol 2019;32:233-46. [PMID: 31040620 DOI: 10.20524/aog.2019.0373] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Mizoguchi A, Takeuchi T, Himuro H, Okada T, Mizoguchi E. Genetically engineered mouse models for studying inflammatory bowel disease. J Pathol. 2016;238:205-219. [PMID: 26387641 DOI: 10.1002/path.4640] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
20 Nguyen PM, Putoczki TL, Ernst M. STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease? J Interferon Cytokine Res. 2015;35:340-350. [PMID: 25760898 DOI: 10.1089/jir.2014.0225] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 7.7] [Reference Citation Analysis]
21 Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011;140:1704-1712. [PMID: 21530736 DOI: 10.1053/j.gastro.2011.02.046] [Cited by in Crossref: 271] [Cited by in F6Publishing: 253] [Article Influence: 24.6] [Reference Citation Analysis]
22 Marlow GJ, van Gent D, Ferguson LR. Why interleukin-10 supplementation does not work in Crohn’s disease patients. World J Gastroenterol 2013; 19(25): 3931-3941 [PMID: 23840137 DOI: 10.3748/wjg.v19.i25.3931] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 77] [Article Influence: 10.2] [Reference Citation Analysis]
23 Rabinowitz K, Mayer L. Working out mechanisms of controlled/physiologic inflammation in the GI tract. Immunol Res. 2012;54:14-24. [PMID: 22466933 DOI: 10.1007/s12026-012-8315-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
24 Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 2013;14:661-73. [PMID: 23917628 DOI: 10.1038/nrg3502] [Cited by in Crossref: 372] [Cited by in F6Publishing: 333] [Article Influence: 41.3] [Reference Citation Analysis]
25 Posovszky C, Barth TFE. [The gut: center of immunity : Rare inflammatory bowel diseases caused by immunodeficiencies]. Pathologe 2020;41:211-23. [PMID: 32253499 DOI: 10.1007/s00292-020-00775-y] [Reference Citation Analysis]
26 Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298-306. [PMID: 21677746 DOI: 10.1038/nature10208] [Cited by in Crossref: 1072] [Cited by in F6Publishing: 1030] [Article Influence: 97.5] [Reference Citation Analysis]
27 Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012;46:581-589. [PMID: 22772738 DOI: 10.1097/mcg.0b013e318247c32f] [Cited by in Crossref: 109] [Cited by in F6Publishing: 31] [Article Influence: 10.9] [Reference Citation Analysis]
28 Wang X, Wong K, Ouyang W, Rutz S. Targeting IL-10 Family Cytokines for the Treatment of Human Diseases. Cold Spring Harb Perspect Biol 2019;11:a028548. [PMID: 29038121 DOI: 10.1101/cshperspect.a028548] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 14.3] [Reference Citation Analysis]
29 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225] [Cited by in Crossref: 1228] [Cited by in F6Publishing: 1209] [Article Influence: 102.3] [Reference Citation Analysis]
30 Jakaitis BM, Denning PW. Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses. Pathophysiology 2014;21:47-54. [PMID: 24440614 DOI: 10.1016/j.pathophys.2013.11.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
31 Zhu L, Shi T, Zhong C, Wang Y, Chang M, Liu X. IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease. Gastroenterology Res 2017;10:65-9. [PMID: 28496525 DOI: 10.14740/gr740w] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
32 Joeris T, Müller-Luda K, Agace WW, Mowat AM. Diversity and functions of intestinal mononuclear phagocytes. Mucosal Immunol 2017;10:845-64. [PMID: 28378807 DOI: 10.1038/mi.2017.22] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 18.8] [Reference Citation Analysis]
33 Charbit-Henrion F, Bègue B, Sierra A, Hanein S, Stolzenberg MC, Li Z, Pellegrini S, Garcelon N, Jeanpierre M, Neven B, Loge I, Picard C, Rosain J, Bustamante J, Le Lorc'h M, Pigneur B, Fernandes A, Rieux-Laucat F, Amil Dias J, Ruemmele FM, Cerf-Bensussan N; GENIUS Group. Copy number variations and founder effect underlying complete IL-10Rβ deficiency in Portuguese kindreds. PLoS One 2018;13:e0205826. [PMID: 30365510 DOI: 10.1371/journal.pone.0205826] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
34 Zaidi D, Wine E. Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases. Front Pediatr 2018;6:317. [PMID: 30425977 DOI: 10.3389/fped.2018.00317] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
35 Bain CC, Mowat AM. The monocyte-macrophage axis in the intestine. Cell Immunol. 2014;291:41-48. [PMID: 24726741 DOI: 10.1016/j.cellimm.2014.03.012] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 10.4] [Reference Citation Analysis]
36 Durant L, Stentz R, Noble A, Brooks J, Gicheva N, Reddi D, O'Connor MJ, Hoyles L, McCartney AL, Man R, Pring ET, Dilke S, Hendy P, Segal JP, Lim DNF, Misra R, Hart AL, Arebi N, Carding SR, Knight SC. Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease. Microbiome 2020;8:88. [PMID: 32513301 DOI: 10.1186/s40168-020-00868-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
37 Mitchell J, Kim SJ, Koukos G, Seelmann A, Veit B, Shepard B, Blumer-Schuette S, Winter HS, Iliopoulos D, Pothoulakis C, Im E, Rhee SH. Colonic Inhibition of Phosphatase and Tensin Homolog Increases Colitogenic Bacteria, Causing Development of Colitis in Il10-/- Mice. Inflamm Bowel Dis 2018;24:1718-32. [PMID: 29788382 DOI: 10.1093/ibd/izy124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
38 Verbsky JW, Chatila TA. T-regulatory cells in primary immune deficiencies. Curr Opin Allergy Clin Immunol 2011;11:539-44. [PMID: 21986549 DOI: 10.1097/ACI.0b013e32834cb8fa] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
39 Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Lencina C, Lévêque M, Braniste V, Ménard S, Théodorou V, Houdeau E. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. PLoS One 2012;7:e49547. [PMID: 23166707 DOI: 10.1371/journal.pone.0049547] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
40 Shimizu T, Marusawa H, Endo Y, Chiba T. Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis. Cancer Sci. 2012;103:1201-1206. [PMID: 22469133 DOI: 10.1111/j.1349-7006.2012.02293.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
41 Segal AW. Making sense of the cause of Crohn's - a new look at an old disease. F1000Res 2016;5:2510. [PMID: 28105308 DOI: 10.12688/f1000research.9699.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
42 Wang S, Yang L, Liu Y, Xu Y, Zhang D, Jiang Z, Wang C, Liu Y. A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia. Front Oncol 2020;10:1579. [PMID: 32850463 DOI: 10.3389/fonc.2020.01579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, Jack RS, Wunderlich FT, Brüning JC, Müller W, Rudensky AY. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011;34:566-78. [PMID: 21511185 DOI: 10.1016/j.immuni.2011.03.018] [Cited by in Crossref: 539] [Cited by in F6Publishing: 516] [Article Influence: 49.0] [Reference Citation Analysis]
44 Ott J, Kamatani Y, Lathrop M. Family-based designs for genome-wide association studies.Nat Rev Genet. 2011;12:465-474. [PMID: 21629274 DOI: 10.1038/nrg2989] [Cited by in Crossref: 194] [Cited by in F6Publishing: 150] [Article Influence: 17.6] [Reference Citation Analysis]
45 Hernandez N, Bucciol G, Moens L, Le Pen J, Shahrooei M, Goudouris E, Shirkani A, Changi-Ashtiani M, Rokni-Zadeh H, Sayar EH, Reisli I, Lefevre-Utile A, Zijlmans D, Jurado A, Pholien R, Drutman S, Belkaya S, Cobat A, Boudewijns R, Jochmans D, Neyts J, Seeleuthner Y, Lorenzo-Diaz L, Enemchukwu C, Tietjen I, Hoffmann HH, Momenilandi M, Pöyhönen L, Siqueira MM, de Lima SMB, de Souza Matos DC, Homma A, Maia MLS, da Costa Barros TA, de Oliveira PMN, Mesquita EC, Gijsbers R, Zhang SY, Seligman SJ, Abel L, Hertzog P, Marr N, Martins RM, Meyts I, Zhang Q, MacDonald MR, Rice CM, Casanova JL, Jouanguy E, Bossuyt X. Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines. J Exp Med 2019;216:2057-70. [PMID: 31270247 DOI: 10.1084/jem.20182295] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 18.0] [Reference Citation Analysis]
46 Tachibana M, Watanabe N, Koda Y, Oya Y, Kaminuma O, Katayama K, Fan Z, Sakurai F, Kawabata K, Hiroi T, Mizuguchi H. Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production. Int Immunol 2020;32:187-201. [PMID: 31755523 DOI: 10.1093/intimm/dxz076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Tang Z, Zhang P, Ji M, Yin C, Zhao R, Huang Z, Huang Y. Characterization of novel and large fragment deletions in exon 1 of the IL10RA gene in Chinese children with very early onset inflammatory bowel diseases. BMC Gastroenterol 2021;21:167. [PMID: 33849446 DOI: 10.1186/s12876-021-01756-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Xu S, Zhou F, Tao J, Song L, Ng SC, Wang X, Chen L, Yi F, Ran Z, Zhou R. Exome sequencing identifies DLG1 as a novel gene for potential susceptibility to Crohn’s disease in a Chinese family study. PLoS One. 2014;9:e99807. [PMID: 24937328 DOI: 10.1371/journal.pone.0099807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
49 Bogunovic D, Boisson-Dupuis S, Casanova JL. ISG15: leading a double life as a secreted molecule. Exp Mol Med 2013;45:e18. [PMID: 23579383 DOI: 10.1038/emm.2013.36] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 7.0] [Reference Citation Analysis]
50 Lord JD. Promises and paradoxes of regulatory T cells in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11236-11245 [PMID: 26523099 DOI: 10.3748/wjg.v21.i40.11236] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
51 Henderson C, Goldbach-Mansky R. Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis. Curr Opin Rheumatol 2010;22:567-78. [PMID: 20671522 DOI: 10.1097/BOR.0b013e32833ceff4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 25] [Article Influence: 0.4] [Reference Citation Analysis]
52 Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM, Posovszky C, Rodrigues A, Russell RK, Barakat F, Auth MKH, Heuschkel R, Zilbauer M, Fyderek K, Braegger C, Travis SP, Satsangi J, Parkes M, Thapar N, Ferry H, Matte JC, Gilmour KC, Wedrychowicz A, Sullivan P, Moore C, Sambrook J, Ouwehand W, Roberts D, Danesh J, Baeumler TA, Fulga TA, Karaminejadranjbar M, Ahmed A, Wilson R, Barrett JC, Elkadri A, Griffiths AM, Snapper SB, Shah N, Muise AM, Wilson DC, Uhlig HH, Anderson CA; COLORS in IBD group investigators., Oxford IBD cohort study investigators., INTERVAL Study., Swiss IBD cohort investigators., UK IBD Genetics Consortium., NIDDK IBD Genetics Consortium. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease. Nat Commun 2020;11:995. [PMID: 32081864 DOI: 10.1038/s41467-019-14275-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
53 Schröder-Braunstein J, Gras J, Brors B, Schwarz S, Szikszai T, Lasitschka F, Wabnitz G, Heidtmann A, Lee YS, Schiessling S, Leowardi C, Al-Saeedi M, Ulrich A, Engelke A, Winter J, Samstag Y, Giese T, Meuer S. Initiation of an inflammatory response in resident intestinal lamina propria cells -use of a human organ culture model. PLoS One 2014;9:e97780. [PMID: 24841635 DOI: 10.1371/journal.pone.0097780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
54 Bain CC, Mowat AM. Macrophages in intestinal homeostasis and inflammation. Immunol Rev. 2014;260:102-117. [PMID: 24942685 DOI: 10.1111/imr.12192.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Landuyt AE, Klocke BJ, Duck LW, Kemp KM, Muir RQ, Jennings MS, Blum SI, Tse HM, Lee G, Morrow CD, Elson CO, Maynard CL. ICOS ligand and IL-10 synergize to promote host-microbiota mutualism. Proc Natl Acad Sci U S A 2021;118:e2018278118. [PMID: 33753483 DOI: 10.1073/pnas.2018278118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Leonardi I, Li X, Iliev ID. Macrophage interactions with fungi and bacteria in inflammatory bowel disease. Curr Opin Gastroenterol 2018;34:392-7. [PMID: 30239343 DOI: 10.1097/MOG.0000000000000479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
57 Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature. 2012;489:231-241. [PMID: 22972296 DOI: 10.1038/nature11551] [Cited by in Crossref: 825] [Cited by in F6Publishing: 754] [Article Influence: 82.5] [Reference Citation Analysis]
58 Di Giovangiulio M, Rizzo A, Franzè E, Caprioli F, Facciotti F, Onali S, Favale A, Stolfi C, Fehling HJ, Monteleone G, Fantini MC. Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis. Front Immunol 2019;10:2158. [PMID: 31572375 DOI: 10.3389/fimmu.2019.02158] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
59 Lanis JM, Alexeev EE, Curtis VF, Kitzenberg DA, Kao DJ, Battista KD, Gerich ME, Glover LE, Kominsky DJ, Colgan SP. Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia. Mucosal Immunol 2017;10:1133-44. [PMID: 28098246 DOI: 10.1038/mi.2016.133] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 15.6] [Reference Citation Analysis]
60 Ye Z, Hu W, Wu B, Zhang Y, Lei C, Williams I, Shouval DS, Kanegane H, Kim KM, de Ridder L, Shah N, Ling G, Yerushalmi B, Kotlarz D, Snapper S, Horn R, Klein C, Muise AM, Huang Y, Uhlig HH. Predictive Prenatal Diagnosis for Infantile-onset Inflammatory Bowel Disease Because of Interleukin-10 Signalling Defects. J Pediatr Gastroenterol Nutr 2021;72:276-81. [PMID: 32925557 DOI: 10.1097/MPG.0000000000002937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Simon JM, Davis JP, Lee SE, Schaner MR, Gipson GR, Weiser M, Sartor RB, Herfarth HH, Rahbar R, Sadiq TS. Alterations to chromatin in intestinal macrophages link IL-10 deficiency to inappropriate inflammatory responses. Eur J Immunol. 2016;46:1912-1925. [PMID: 27159132 DOI: 10.1002/eji.201546237] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
62 Duncan CJA, Randall RE, Hambleton S. Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity. Trends Genet 2021;37:46-58. [PMID: 32977999 DOI: 10.1016/j.tig.2020.08.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
63 Goettel JA, Gandhi R, Kenison JE, Yeste A, Murugaiyan G, Sambanthamoorthy S, Griffith AE, Patel B, Shouval DS, Weiner HL, Snapper SB, Quintana FJ. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice. Cell Rep 2016;17:1318-29. [PMID: 27783946 DOI: 10.1016/j.celrep.2016.09.082] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 18.0] [Reference Citation Analysis]
64 Kierkus J, Szymanska E, Oracz G, Wiernicka A, Dadalski M. Profile of infliximab in the treatment of pediatric Crohn's disease. Pediatric Health Med Ther 2015;6:79-85. [PMID: 29388577 DOI: 10.2147/PHMT.S64943] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Danne C, Ryzhakov G, Martínez-López M, Ilott NE, Franchini F, Cuskin F, Lowe EC, Bullers SJ, Arthur JSC, Powrie F. A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages. Cell Host Microbe 2017;22:733-745.e5. [PMID: 29241040 DOI: 10.1016/j.chom.2017.11.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
66 Al-Abbasi FA, Mohammed K, Sadath S, Banaganapalli B, Nasser K, Shaik NA. Computational Protein Phenotype Characterization of IL10RA Mutations Causative to Early Onset Inflammatory Bowel Disease (IBD). Front Genet 2018;9:146. [PMID: 29755507 DOI: 10.3389/fgene.2018.00146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
67 Bates J, Diehl L. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J Pathol. 2014;232:112-120. [PMID: 24122796 DOI: 10.1002/path.4277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
68 Nishio J, Honda K. Immunoregulation by the gut microbiota. Cell Mol Life Sci. 2012;69:3635-3650. [PMID: 22527722 DOI: 10.1007/s00018-012-0993-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
69 Swaminathan A, Sathiyasekaran M, Padankatti S, Padankatti RB, Arulprakash S, Raj R. A Rare Cause of Rectovaginal Fistula in Early Infancy: It is in the Genes! J Indian Assoc Pediatr Surg 2021;26:442-4. [PMID: 34912145 DOI: 10.4103/jiaps.JIAPS_217_20] [Reference Citation Analysis]
70 DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflamm Bowel Dis. 2016;22:1137-1150. [PMID: 27070911 DOI: 10.1097/mib.0000000000000750] [Cited by in Crossref: 233] [Cited by in F6Publishing: 134] [Article Influence: 46.6] [Reference Citation Analysis]
71 Broggi A, Tan Y, Granucci F, Zanoni I. IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function. Nat Immunol 2017;18:1084-93. [PMID: 28846084 DOI: 10.1038/ni.3821] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 21.6] [Reference Citation Analysis]
72 Dulai PS, Siegel CA, Dubinsky MC. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2927-36. [PMID: 23867874 DOI: 10.1097/MIB.0b013e31829aad16] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
73 Rosen MJ. New Role for Fatty Acid Receptor Regulation of Immune Cells to Control Intestinal Inflammation. Gastroenterology 2021:S0016-5085(21)03647-7. [PMID: 34672998 DOI: 10.1053/j.gastro.2021.09.072] [Reference Citation Analysis]
74 Poddar U, Yachha SK, Srivastava A, Kumari N. Pediatric inflammatory bowel disease: Is it really uncommon in Asian children? JGH Open 2020;4:860-6. [PMID: 33102756 DOI: 10.1002/jgh3.12330] [Reference Citation Analysis]
75 Saito MK. Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells. Children (Basel) 2021;8:94. [PMID: 33535645 DOI: 10.3390/children8020094] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Ludigs K, Parfenov V, Du Pasquier RA, Guarda G. Type I IFN-mediated regulation of IL-1 production in inflammatory disorders. Cell Mol Life Sci 2012;69:3395-418. [PMID: 22527721 DOI: 10.1007/s00018-012-0989-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
77 Wu W, Chen F, Liu Z, Cong Y. Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1473-82. [PMID: 27057688 DOI: 10.1097/MIB.0000000000000775] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
78 Pascual V, Dieli-Crimi R, López-Palacios N, Bodas A, Medrano LM, Núñez C. Inflammatory bowel disease and celiac disease: Overlaps and differences. World J Gastroenterol 2014; 20(17): 4846-4856 [PMID: 24803796 DOI: 10.3748/wjg.v20.i17.4846] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
79 Hanyang L, Xuanzhe L, Xuyang C, Yujia Q, Jiarong F, Jun S, Zhihua R. Application of Zebrafish Models in Inflammatory Bowel Disease. Front Immunol 2017;8:501. [PMID: 28515725 DOI: 10.3389/fimmu.2017.00501] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
80 Koelink PJ, Bloemendaal FM, Li B, Westera L, Vogels EWM, van Roest M, Gloudemans AK, van 't Wout AB, Korf H, Vermeire S, Te Velde AA, Ponsioen CY, D'Haens GR, Verbeek JS, Geiger TL, Wildenberg ME, van den Brink GR. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling. Gut 2020;69:1053-63. [PMID: 31506328 DOI: 10.1136/gutjnl-2019-318264] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
81 Chen ML, Sundrud MS. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:1157-1167. [PMID: 26863267 DOI: 10.1097/mib.000000 0000000714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Crandall WV, Baldassano R, Bousvaros A, Denson LA, Gupta N, Mackner LM. NASPGHAN single-topic symposium: discovering the future of pediatric IBD care. J Pediatr Gastroenterol Nutr. 2014;58:130-138. [PMID: 24378522 DOI: 10.1097/mpg.0000000000000178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Moon JS. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr. 2019;22:50-56. [PMID: 30671373 DOI: 10.5223/pghn.2019.22.1.50] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
84 Cabezón R, Benítez-Ribas D. Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application. Clin Dev Immunol. 2013;2013:789814. [PMID: 24319468 DOI: 10.1155/2013/789814] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
85 Gasparetto M, Guariso G. Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age. Gastroenterol Res Pract. 2013;2013:829040. [PMID: 24454343 DOI: 10.1155/2013/829040] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 6.2] [Reference Citation Analysis]
86 Saleh M, Elson CO. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity. 2011;34:293-302. [PMID: 21435584 DOI: 10.1016/j.immuni.2011.03.008] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 10.1] [Reference Citation Analysis]
87 Kim KY, Lee EJ, Kim JW, Moon JS, Jang JY, Yang HR, Ko JS. Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2018;21:34-42. [PMID: 29383303 DOI: 10.5223/pghn.2018.21.1.34] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
88 Frede N, Glocker EO, Wanders J, Engelhardt KR, Kreisel W, Ruemmele FM, Grimbacher B. Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease. BMC Immunol 2014;15:10. [PMID: 24581234 DOI: 10.1186/1471-2172-15-10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
89 MacKenzie KF, Clark K, Naqvi S, McGuire VA, Nöehren G, Kristariyanto Y, van den Bosch M, Mudaliar M, McCarthy PC, Pattison MJ, Pedrioli PG, Barton GJ, Toth R, Prescott A, Arthur JS. PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway. J Immunol 2013;190:565-77. [PMID: 23241891 DOI: 10.4049/jimmunol.1202462] [Cited by in Crossref: 146] [Cited by in F6Publishing: 138] [Article Influence: 14.6] [Reference Citation Analysis]
90 Stefan KL, Fink A, Surana NK, Kasper DL, Dasgupta S. Type I interferon signaling restrains IL-10R+ colonic macrophages and dendritic cells and leads to more severe Salmonella colitis. PLoS One 2017;12:e0188600. [PMID: 29190678 DOI: 10.1371/journal.pone.0188600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
91 Long AG, Lundsmith ET, Hamilton KE. Inflammation and Colorectal Cancer. Curr Colorectal Cancer Rep. 2017;13:341-351. [PMID: 29129972 DOI: 10.1007/s11888-017-0373-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
92 Saraiva M, Vieira P, O'Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med 2020;217:e20190418. [PMID: 31611251 DOI: 10.1084/jem.20190418] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 23.5] [Reference Citation Analysis]
93 Hutchins AP, Takahashi Y, Miranda-Saavedra D. Genomic analysis of LPS-stimulated myeloid cells identifies a common pro-inflammatory response but divergent IL-10 anti-inflammatory responses. Sci Rep. 2015;5:9100. [PMID: 25765318 DOI: 10.1038/srep09100] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
94 Lehman HK. Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders. Curr Allergy Asthma Rep 2015;15:53. [PMID: 26233425 DOI: 10.1007/s11882-015-0553-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
95 Werner L, Lee YN, Rechavi E, Lev A, Yerushalmi B, Ling G, Shah N, Uhlig HH, Weiss B, Somech R, Snapper SB, Shouval DS. Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD. Front Immunol 2020;11:109. [PMID: 32117262 DOI: 10.3389/fimmu.2020.00109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
96 Giannelou A, Zhou Q, Kastner DL. When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol 2014;14:491-500. [PMID: 25337682 DOI: 10.1097/ACI.0000000000000117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
97 McGuire VA, Rosner D, Ananieva O, Ross EA, Elcombe SE, Naqvi S, van den Bosch MMW, Monk CE, Ruiz-Zorrilla Diez T, Clark AR, Arthur JSC. Beta Interferon Production Is Regulated by p38 Mitogen-Activated Protein Kinase in Macrophages via both MSK1/2- and Tristetraprolin-Dependent Pathways. Mol Cell Biol 2017;37:e00454-16. [PMID: 27795299 DOI: 10.1128/MCB.00454-16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
98 Karmele EP, Pasricha TS, Ramalingam TR, Thompson RW, Gieseck RL 3rd, Knilans KJ, Hegen M, Farmer M, Jin F, Kleinman A, Hinds DA, Almeida Pereira T, de Queiroz Prado R, Bing N, Tchistiakova L, Kasaian MT, Wynn TA, Vannella KM; 23andMe Research Team. Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease. Mucosal Immunol 2019;12:1174-86. [PMID: 31308480 DOI: 10.1038/s41385-019-0189-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
99 Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell 2011;147:44-56. [PMID: 21962506 DOI: 10.1016/j.cell.2011.09.009] [Cited by in Crossref: 150] [Cited by in F6Publishing: 128] [Article Influence: 13.6] [Reference Citation Analysis]
100 Harrison OJ, Powrie FM. Regulatory T cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol 2013;5:a018341. [PMID: 23818502 DOI: 10.1101/cshperspect.a018341] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 7.6] [Reference Citation Analysis]
101 Fritz T, Niederreiter L, Tilg H, Blumberg RS, Kaser A. Controversy over NOD2, inflammation, and defensins. Inflamm Bowel Dis 2010;16:1996-8. [PMID: 20128000 DOI: 10.1002/ibd.21213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
102 Im E, Jung J, Pothoulakis C, Rhee SH. Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10(-/-) mice. Gastroenterology 2014;147:667-679.e10. [PMID: 24882466 DOI: 10.1053/j.gastro.2014.05.034] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
103 Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol. 2010;10:735-744. [PMID: 20865020 DOI: 10.1038/nri2850] [Cited by in Crossref: 417] [Cited by in F6Publishing: 371] [Article Influence: 34.8] [Reference Citation Analysis]
104 Bamias G, Dahman MI, Arseneau KO, Guanzon M, Gruska D, Pizarro TT, Cominelli F. Intestinal-specific TNFα overexpression induces Crohn's-like ileitis in mice. PLoS One 2013;8:e72594. [PMID: 23977323 DOI: 10.1371/journal.pone.0072594] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
105 Zhou L, Sonnenberg GF. Essential immunologic orchestrators of intestinal homeostasis. Sci Immunol. 2018;3. [PMID: 29440266 DOI: 10.1126/sciimmunol.aao1605] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
106 Ackermann M, Mucci A, McCabe A, Frei S, Wright K, Snapper SB, Lachmann N, Williams DA, Brendel C. Restored Macrophage Function Ameliorates Disease Pathophysiology in a Mouse Model for IL10 Receptor-deficient Very Early Onset Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1588-95. [PMID: 33596307 DOI: 10.1093/ecco-jcc/jjab031] [Reference Citation Analysis]
107 Jarry A, Bossard C, Droy-Dupré L, Volteau C, Bourreille A, Meurette G, Mosnier JF, Laboisse CL. Heterogeneity of subordination of the IL-18/IFN-γ axis to caspase-1 among patients with Crohn's disease. Lab Invest 2015;95:1207-17. [PMID: 26168332 DOI: 10.1038/labinvest.2015.89] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
108 Shim JO, Seo JK. Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations. J Hum Genet. 2014;59:337-341. [PMID: 24785691 DOI: 10.1038/jhg.2014.32] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
109 Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667-685. [PMID: 25234148 DOI: 10.1038/nri3738] [Cited by in Crossref: 647] [Cited by in F6Publishing: 600] [Article Influence: 80.9] [Reference Citation Analysis]
110 Girardelli M, Vuch J, Tommasini A, Crovella S, Bianco AM. Novel missense mutation in the NOD2 gene in a patient with early onset ulcerative colitis: causal or chance association? Int J Mol Sci 2014;15:3834-41. [PMID: 24595243 DOI: 10.3390/ijms15033834] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
111 Kammermeier J, Dziubak R, Pescarin M, Drury S, Godwin H, Reeve K, Chadokufa S, Huggett B, Sider S, James C, Acton N, Cernat E, Gasparetto M, Noble-Jamieson G, Kiparissi F, Elawad M, Beales PL, Sebire NJ, Gilmour K, Uhlig HH, Bacchelli C, Shah N. Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years. J Crohns Colitis. 2017;11:60-69. [PMID: 27302973 DOI: 10.1093/ecco-jcc/jjw118] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
112 Horowitz JE, Warner N, Staples J, Crowley E, Gosalia N, Murchie R, Van Hout C, Fiedler K, Welch G, King AK, Reid JG, Overton JD, Baras A, Shuldiner AR, Griffiths A, Gottesman O, Muise AM, Gonzaga-Jauregui C. Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn's Disease. Sci Rep 2021;11:5595. [PMID: 33692434 DOI: 10.1038/s41598-021-84938-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
113 Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quévrain E, Bridonneau C, Preisser L, Asehnoune K, Labarrière N. CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease. PLoS Biol. 2014;12:e1001833. [PMID: 24714093 DOI: 10.1371/journal.pbio.1001833] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 8.9] [Reference Citation Analysis]
114 Pazmandi J, Kalinichenko A, Ardy RC, Boztug K. Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms. Immunol Rev 2019;287:162-85. [PMID: 30565237 DOI: 10.1111/imr.12726] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
115 Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep 2020;47:3053-63. [PMID: 32086718 DOI: 10.1007/s11033-020-05318-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
116 Vardi I, Chermesh I, Werner L, Barel O, Freund T, McCourt C, Fisher Y, Pinsker M, Javasky E, Weiss B, Rechavi G, Hagin D, Snapper SB, Somech R, Konnikova L, Shouval DS. Monogenic Inflammatory Bowel Disease: It's Never Too Late to Make a Diagnosis. Front Immunol 2020;11:1775. [PMID: 33013830 DOI: 10.3389/fimmu.2020.01775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Autio K, Oft M. Pegylated Interleukin-10: Clinical Development of an Immunoregulatory Cytokine for Use in Cancer Therapeutics. Curr Oncol Rep 2019;21:19. [PMID: 30790069 DOI: 10.1007/s11912-019-0760-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
118 Bishop J, Lemberg DA, Day A. Managing inflammatory bowel disease in adolescent patients. Adolesc Health Med Ther. 2014;5:1-13. [PMID: 24729736 DOI: 10.2147/ahmt.s37956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
119 Filardy AA, He J, Bennink J, Yewdell J, Kelsall BL. Posttranscriptional control of NLRP3 inflammasome activation in colonic macrophages. Mucosal Immunol 2016;9:850-8. [PMID: 26627461 DOI: 10.1038/mi.2015.109] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
120 Kaser A, Blumberg RS. Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology. 2011;140:1738-1747. [PMID: 21530740 DOI: 10.1053/j.gastro.2011.02.048] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 9.2] [Reference Citation Analysis]
121 Okou DT, Kugathasan S. Role of genetics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2014;20:1878-84. [PMID: 25118609 DOI: 10.1097/MIB.0000000000000085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
122 Bamias G, Pizarro TT, Cominelli F. Pathway-based approaches to the treatment of inflammatory bowel disease. Transl Res 2016;167:104-15. [PMID: 26408803 DOI: 10.1016/j.trsl.2015.09.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
123 Chamberlain TC, Cheung ST, Yoon JSJ, Ming-Lum A, Gardill BR, Shakibakho S, Dzananovic E, Ban F, Samiea A, Jawanda K, Priatel J, Krystal G, Ong CJ, Cherkasov A, Andersen RJ, McKenna SA, Van Petegem F, Mui AL. Interleukin-10 and Small Molecule SHIP1 Allosteric Regulators Trigger Anti-inflammatory Effects through SHIP1/STAT3 Complexes. iScience 2020;23:101433. [PMID: 32823063 DOI: 10.1016/j.isci.2020.101433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
124 Arora M, Bagi P, Strongin A, Heimall J, Zhao X, Lawrence MG, Trivedi A, Henderson C, Hsu A, Quezado M, Kleiner DE, Venkatesan AM, Holland SM, Freeman AF, Heller T. Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome. J Clin Immunol 2017;37:695-700. [PMID: 28803389 DOI: 10.1007/s10875-017-0429-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
125 Cabral-Marques O, Schimke LF, de Oliveira EB Jr, El Khawanky N, Ramos RN, Al-Ramadi BK, Segundo GRS, Ochs HD, Condino-Neto A. Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation. Front Immunol 2019;10:2742. [PMID: 31849949 DOI: 10.3389/fimmu.2019.02742] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
126 Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol 2020;146:925-37. [PMID: 33160483 DOI: 10.1016/j.jaci.2020.08.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
127 Jéru I. Update on the Genetics of Autoinflammatory Disorders. Curr Allergy Asthma Rep 2019;19:41. [PMID: 31321571 DOI: 10.1007/s11882-019-0874-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
128 Fan YM, Zhang LF, Zhao Y, Chen LL. Significance of RhoC and IQGAP1 expression in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(27): 2841-2845 [DOI: 10.11569/wcjd.v19.i27.2841] [Reference Citation Analysis]
129 Zhang ZZ, Zhang Y, He T, Sweeney CL, Baris S, Karakoc-Aydiner E, Yao Y, Ertem D, Matthews HF, Gonzaga-Jauregui C, Malech HL, Su HC, Ozen A, Smith KGC, Lenardo MJ. Homozygous IL37 mutation associated with infantile inflammatory bowel disease. Proc Natl Acad Sci U S A 2021;118:e2009217118. [PMID: 33674380 DOI: 10.1073/pnas.2009217118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
130 Buckley A, Turner JR. Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease. Cold Spring Harb Perspect Biol 2018;10:a029314. [PMID: 28507021 DOI: 10.1101/cshperspect.a029314] [Cited by in Crossref: 148] [Cited by in F6Publishing: 145] [Article Influence: 37.0] [Reference Citation Analysis]
131 Hidalgo-Garcia L, Galvez J, Rodriguez-Cabezas ME, Anderson PO. Can a Conversation Between Mesenchymal Stromal Cells and Macrophages Solve the Crisis in the Inflamed Intestine? Front Pharmacol 2018;9:179. [PMID: 29559912 DOI: 10.3389/fphar.2018.00179] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
132 Attarwala H, Han M, Kim J, Amiji M. Oral nucleic acid therapy using multicompartmental delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2018;10. [PMID: 28544521 DOI: 10.1002/wnan.1478] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
133 Eichenberger RM, Ryan S, Jones L, Buitrago G, Polster R, Montes de Oca M, Zuvelek J, Giacomin PR, Dent LA, Engwerda CR, Field MA, Sotillo J, Loukas A. Hookworm Secreted Extracellular Vesicles Interact With Host Cells and Prevent Inducible Colitis in Mice. Front Immunol 2018;9:850. [PMID: 29760697 DOI: 10.3389/fimmu.2018.00850] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 21.5] [Reference Citation Analysis]
134 Comi M, Amodio G, Gregori S. Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells. Front Immunol 2018;9:682. [PMID: 29686676 DOI: 10.3389/fimmu.2018.00682] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
135 Uhlig HH, Charbit-Henrion F, Kotlarz D, Shouval DS, Schwerd T, Strisciuglio C, de Ridder L, van Limbergen J, Macchi M, Snapper SB, Ruemmele FM, Wilson DC, Travis SPL, Griffiths AM, Turner D, Klein C, Muise AM, Russell RK; Paediatric IBD Porto group of ESPGHAN. Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2021;72:456-73. [PMID: 33346580 DOI: 10.1097/MPG.0000000000003017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
136 Li Q, Lee CH, Peters LA, Mastropaolo LA, Thoeni C, Elkadri A, Schwerd T, Zhu J, Zhang B, Zhao Y. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease. Gastroenterology. 2016;150:1196-1207. [PMID: 26836588 DOI: 10.1053/j.gastro.2016.01.031] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 9.5] [Reference Citation Analysis]
137 Escors D. Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. New J Sci. 2014;2014:pii 734515. [PMID: 24634791 DOI: 10.1155/2014/734515] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
138 Lafarge S, Hamzeh-Cognasse H, Richard Y, Pozzetto B, Cogné M, Cognasse F, Garraud O. Complexes between nuclear factor-κB p65 and signal transducer and activator of transcription 3 are key actors in inducing activation-induced cytidine deaminase expression and immunoglobulin A production in CD40L plus interleukin-10-treated human blood B cells. Clin Exp Immunol 2011;166:171-83. [PMID: 21985363 DOI: 10.1111/j.1365-2249.2011.04465.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
139 Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol. 2010;8:564-577. [PMID: 20622892 DOI: 10.1038/nrmicro2403] [Cited by in Crossref: 223] [Cited by in F6Publishing: 226] [Article Influence: 18.6] [Reference Citation Analysis]
140 Keith BP, Barrow JB, Toyonaga T, Kazgan N, O'Connor MH, Shah ND, Schaner MS, Wolber EA, Trad OK, Gipson GR, Pitman WA, Kanke M, Saxena SJ, Chaumont N, Sadiq TS, Koruda MJ, Cotney PA, Allbritton N, Trembath DG, Sylvester F, Furey TS, Sethupathy P, Sheikh SZ. Colonic epithelial miR-31 associates with the development of Crohn's phenotypes. JCI Insight 2018;3:122788. [PMID: 30282822 DOI: 10.1172/jci.insight.122788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
141 Marel SVD, Majowicz A, Deventer SV, Petry H, Hommes DW, Ferreira V. Gene and cell therapy based treatment strategies for inflammatory bowel diseases. World J Gastrointest Pathophysiol 2011; 2(6): 114-122 [PMID: 22180846 DOI: 10.4291/wjgp.v2.i6.114] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
142 Kuşkonmaz B, Ayvaz D, Aydemir Y, Erman B, Tavil B, Özen H, Tezcan I, Çetinkaya DU. Successful outcome with second hematopoietic stem cell transplantation in a patient with IL-10R deficiency. Bone Marrow Transplant 2016;51:615-6. [PMID: 26691419 DOI: 10.1038/bmt.2015.310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
143 Otter D, Cao M, Lin HM, Fraser K, Edmunds S, Lane G, Rowan D. Identification of urinary biomarkers of colon inflammation in IL10-/- mice using Short-Column LCMS metabolomics. J Biomed Biotechnol. 2011;2011:974701. [PMID: 21188174 DOI: 10.1155/2011/974701] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
144 Zhang M, Zhou Q, Dorfman RG, Huang X, Fan T, Zhang H, Zhang J, Yu C. Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol. 2016;16:84. [PMID: 27473867 DOI: 10.1186/s12876-016-0500-x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 14.5] [Reference Citation Analysis]
145 Sawant DV, Hamilton K, Vignali DA. Interleukin-35: Expanding Its Job Profile. J Interferon Cytokine Res 2015;35:499-512. [PMID: 25919641 DOI: 10.1089/jir.2015.0015] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
146 Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel diseases. World J Gastroenterol 2020; 26(28): 3998-4017 [PMID: 32821067 DOI: 10.3748/wjg.v26.i28.3998] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
147 Salem HA, Wadie W. Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis. Sci Rep 2017;7:7139. [PMID: 28769047 DOI: 10.1038/s41598-017-07280-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
148 Cheung ST, So EY, Chang D, Ming-Lum A, Mui AL. Interleukin-10 inhibits lipopolysaccharide induced miR-155 precursor stability and maturation. PLoS One 2013;8:e71336. [PMID: 23951138 DOI: 10.1371/journal.pone.0071336] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
149 Li B, Alli R, Vogel P, Geiger TL. IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis. Mucosal Immunol. 2014;7:869-878. [PMID: 24301657 DOI: 10.1038/mi.2013.103] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 10.6] [Reference Citation Analysis]
150 Charbit-Henrion F, Parlato M, Hanein S, Duclaux-Loras R, Nowak J, Begue B, Rakotobe S, Bruneau J, Fourrage C, Alibeu O, Rieux-Laucat F, Lévy E, Stolzenberg MC, Mazerolles F, Latour S, Lenoir C, Fischer A, Picard C, Aloi M, Dias JA, Hariz MB, Bourrier A, Breuer C, Breton A, Bronsky J, Buderus S, Cananzi M, Coopman S, Crémilleux C, Dabadie A, Dumant-Forest C, Gurkan OE, Fabre A, Fischer A, Diaz MG, Gonzalez-Lama Y, Goulet O, Guariso G, Gurcan N, Homan M, Hugot JP, Jeziorski E, Karanika E, Lachaux A, Lewindon P, Lima R, Magro F, Major J, Malamut G, Mas E, Mattyus I, Mearin LM, Melek J, Navas-Lopez VM, Paerregaard A, Pelatan C, Pigneur B, Pais IP, Rebeuh J, Romano C, Siala N, Strisciuglio C, Tempia-Caliera M, Tounian P, Turner D, Urbonas V, Willot S, Ruemmele FM, Cerf-Bensussan N. Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study. J Crohns Colitis 2018;12:1104-12. [PMID: 29788237 DOI: 10.1093/ecco-jcc/jjy068] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
151 Stettner N, Rosen C, Bernshtein B, Gur-Cohen S, Frug J, Silberman A, Sarver A, Carmel-Neiderman NN, Eilam R, Biton I, Pevsner-Fischer M, Zmora N, Brandis A, Bahar Halpern K, Mazkereth R, di Bernardo D, Brunetti-Pierri N, Premkumar MH, Dank G, Nagamani SCS, Jung S, Harmelin A, Erez A. Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon Cancer. Cell Rep 2018;23:1962-76. [PMID: 29768197 DOI: 10.1016/j.celrep.2018.04.053] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
152 Gambineri E. New frontiers in primary immunodeficiency disorders: immunology and beyond…. Cell Mol Life Sci 2012;69:1-5. [PMID: 22009453 DOI: 10.1007/s00018-011-0833-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
153 Stavsky J, Maitra R. The Synergistic Role of Diet and Exercise in the Prevention, Pathogenesis, and Management of Ulcerative Colitis: An Underlying Metabolic Mechanism. Nutr Metab Insights 2019;12:1178638819834526. [PMID: 30911221 DOI: 10.1177/1178638819834526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
154 Martinon F, Aksentijevich I. New players driving inflammation in monogenic autoinflammatory diseases. Nat Rev Rheumatol. 2015;11:11-20. [PMID: 25247411 DOI: 10.1038/nrrheum.2014.158] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
155 Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the 'epimmunome'. Nat Immunol 2010;11:656-65. [PMID: 20644571 DOI: 10.1038/ni.1905] [Cited by in Crossref: 205] [Cited by in F6Publishing: 197] [Article Influence: 17.1] [Reference Citation Analysis]
156 Li LJ, Gong C, Zhao MH, Feng BS. Role of interleukin-22 in inflammatory bowel disease. World J Gastroenterol 2014; 20(48): 18177-18188 [PMID: 25561785 DOI: 10.3748/wjg.v20.i48.18177] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
157 Renz H, Brandtzaeg P, Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol. 2011;12:9-23. [PMID: 22158411 DOI: 10.1038/nri3112] [Cited by in Crossref: 301] [Cited by in F6Publishing: 285] [Article Influence: 27.4] [Reference Citation Analysis]
158 Saha P, Golonka RM, Abokor AA, Yeoh BS, Vijay-Kumar M. IL-10 Receptor Neutralization-Induced Colitis in Mice: A Comprehensive Guide. Curr Protoc 2021;1:e227. [PMID: 34399038 DOI: 10.1002/cpz1.227] [Reference Citation Analysis]
159 Denson LA. How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients? Curr Gastroenterol Rep 2012;14:275-81. [PMID: 22422506 DOI: 10.1007/s11894-012-0258-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
160 Roifman CM, Grunebaum E. Primary T-cell immunodeficiencies. Clinical Immunology. Elsevier; 2013. pp. 437-53. [DOI: 10.1016/b978-0-7234-3691-1.00052-0] [Reference Citation Analysis]
161 Miller TL, Lee D, Giefer M, Wahbeh G, Suskind DL. Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report. Dig Dis Sci 2017;62:2196-200. [PMID: 28551707 DOI: 10.1007/s10620-017-4616-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
162 Ouahed J. Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:1870-2. [PMID: 34525210 DOI: 10.1093/ibd/izab145] [Reference Citation Analysis]
163 Rigoli L, Caruso RA. Inflammatory bowel disease in pediatric and adolescent patients: A biomolecular and histopathological review. World J Gastroenterol 2014; 20(30): 10262-10278 [PMID: 25132743 DOI: 10.3748/wjg.v20.i30.10262] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
164 Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317. [PMID: 21677747 DOI: 10.1038/nature10209] [Cited by in Crossref: 1401] [Cited by in F6Publishing: 1305] [Article Influence: 127.4] [Reference Citation Analysis]
165 Mizoguchi A, Yano A, Himuro H, Ezaki Y, Sadanaga T, Mizoguchi E. Clinical importance of IL-22 cascade in IBD. J Gastroenterol 2018;53:465-74. [PMID: 29075900 DOI: 10.1007/s00535-017-1401-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 12.4] [Reference Citation Analysis]
166 Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, Agematsu K, Yamada M, Kawamura N, Ariga T, Tsuge I, Nonoyama S, Karasuyama H, Minegishi Y. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med 2011;208:235-49. [PMID: 21300911 DOI: 10.1084/jem.20100799] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 7.5] [Reference Citation Analysis]
167 Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012;3:107. [PMID: 22586430 DOI: 10.3389/fimmu.2012.00107] [Cited by in Crossref: 192] [Cited by in F6Publishing: 191] [Article Influence: 19.2] [Reference Citation Analysis]
168 Traxinger BR, Richert-Spuhler LE, Lund JM. Mucosal tissue regulatory T cells are integral in balancing immunity and tolerance at portals of antigen entry. Mucosal Immunol 2021. [PMID: 34845322 DOI: 10.1038/s41385-021-00471-x] [Reference Citation Analysis]
169 Li Y, Führer M, Bahrami E, Socha P, Klaudel-Dreszler M, Bouzidi A, Liu Y, Lehle AS, Magg T, Hollizeck S, Rohlfs M, Conca R, Field M, Warner N, Mordechai S, Shteyer E, Turner D, Boukari R, Belbouab R, Walz C, Gaidt MM, Hornung V, Baumann B, Pannicke U, Al Idrissi E, Ali Alghamdi H, Sepulveda FE, Gil M, de Saint Basile G, Hönig M, Koletzko S, Muise AM, Snapper SB, Schwarz K, Klein C, Kotlarz D. Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases. Proc Natl Acad Sci U S A 2019;116:970-5. [PMID: 30591564 DOI: 10.1073/pnas.1813582116] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 15.8] [Reference Citation Analysis]
170 Geem D, Harusato A, Flannigan K, Denning TL. Harnessing regulatory T cells for the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1409-1418. [PMID: 25793328 DOI: 10.1097/mib.0000000000000343] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
171 Fransen K, Mitrovic M, van Diemen CC, Weersma RK. The quest for genetic risk factors for Crohn's disease in the post-GWAS era. Genome Med 2011;3:13. [PMID: 21392414 DOI: 10.1186/gm227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
172 Arai K. Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists. Pediatr Gastroenterol Hepatol Nutr 2020;23:411-22. [PMID: 32953636 DOI: 10.5223/pghn.2020.23.5.411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
173 Rohr J, Pannicke U, Döring M, Schmitt-Graeff A, Wiech E, Busch A, Speckmann C, Müller I, Lang P, Handgretinger R. Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency. J Clin Immunol. 2010;30:314-320. [PMID: 19967552 DOI: 10.1007/s10875-009-9349-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
174 Parlato M, Yeretssian G. NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci. 2014;15:9594-9627. [PMID: 24886810 DOI: 10.3390/ijms15069594] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
175 Zheng L, Kelly CJ, Battista KD, Schaefer R, Lanis JM, Alexeev EE, Wang RX, Onyiah JC, Kominsky DJ, Colgan SP. Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor-Dependent Repression of Claudin-2. J Immunol 2017;199:2976-84. [PMID: 28893958 DOI: 10.4049/jimmunol.1700105] [Cited by in Crossref: 142] [Cited by in F6Publishing: 139] [Article Influence: 28.4] [Reference Citation Analysis]
176 Tyagi RK, Li J, Jacobse J, Snapper SB, Shouval DS, Goettel JA. Humanized mouse models of genetic immune disorders and hematological malignancies. Biochem Pharmacol 2020;174:113671. [PMID: 31634456 DOI: 10.1016/j.bcp.2019.113671] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
177 Aktas B, De Wolfe TJ, Tandee K, Safdar N, Darien BJ, Steele JL. The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent. PLoS One 2015;10:e0145784. [PMID: 26714177 DOI: 10.1371/journal.pone.0145784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
178 Yanagi T, Mizuochi T, Takaki Y, Eda K, Mitsuyama K, Ishimura M, Takada H, Shouval DS, Griffith AE, Snapper SB, Yamashita Y, Yamamoto K. Novel exonic mutation inducing aberrant splicing in the IL10RA gene and resulting in infantile-onset inflammatory bowel disease: a case report. BMC Gastroenterol. 2016;16:10. [PMID: 26822028 DOI: 10.1186/s12876-016-0424-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
179 Girard-Madoux MJ, Ober-Blöbaum JL, Costes LM, Kel JM, Lindenbergh-Kortleve DJ, Brouwers-Haspels I, Heikema AP, Samsom JN, Clausen BE. IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine. Oncotarget 2016;7:32015-30. [PMID: 27027442 DOI: 10.18632/oncotarget.8337] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
180 Gross-Vered M, Trzebanski S, Shemer A, Bernshtein B, Curato C, Stelzer G, Salame TM, David E, Boura-Halfon S, Chappell-Maor L, Leshkowitz D, Jung S. Defining murine monocyte differentiation into colonic and ileal macrophages. Elife 2020;9:e49998. [PMID: 31916932 DOI: 10.7554/eLife.49998] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
181 Bastard P, Manry J, Chen J, Rosain J, Seeleuthner Y, AbuZaitun O, Lorenzo L, Khan T, Hasek M, Hernandez N, Bigio B, Zhang P, Lévy R, Shrot S, Reino EJG, Lee YS, Boucherit S, Aubart M, Gijsbers R, Béziat V, Li Z, Pellegrini S, Rozenberg F, Marr N, Meyts I, Boisson B, Cobat A, Bustamante J, Zhang Q, Jouangy E, Abel L, Somech R, Casanova JL, Zhang SY. Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency. J Clin Invest 2021;131:139980. [PMID: 32960813 DOI: 10.1172/JCI139980] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
182 Brunsing RL, Prossnitz ER. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. Immunology. 2011;134:93-106. [PMID: 21722102 DOI: 10.1111/j.1365-2567.2011.03471.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
183 Hansen IS, Schoonejans JM, Sritharan L, van Burgsteden JA, Ambarus CA, Baeten DLP, den Dunnen J. ER stress abrogates the immunosuppressive effect of IL-10 on human macrophages through inhibition of STAT3 activation. Inflamm Res 2019;68:775-85. [PMID: 31227842 DOI: 10.1007/s00011-019-01261-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
184 Kelsen JR, Baldassano RN. The role of monogenic disease in children with very early onset inflammatory bowel disease. Curr Opin Pediatr 2017;29:566-71. [PMID: 28700415 DOI: 10.1097/MOP.0000000000000531] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
185 Hernandez N, Melki I, Jing H, Habib T, Huang SSY, Danielson J, Kula T, Drutman S, Belkaya S, Rattina V, Lorenzo-Diaz L, Boulai A, Rose Y, Kitabayashi N, Rodero MP, Dumaine C, Blanche S, Lebras MN, Leung MC, Mathew LS, Boisson B, Zhang SY, Boisson-Dupuis S, Giliani S, Chaussabel D, Notarangelo LD, Elledge SJ, Ciancanelli MJ, Abel L, Zhang Q, Marr N, Crow YJ, Su HC, Casanova JL. Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency. J Exp Med 2018;215:2567-85. [PMID: 30143481 DOI: 10.1084/jem.20180628] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 19.3] [Reference Citation Analysis]
186 Lv JJ, Su W, Chen XY, Yu Y, Xu X, Xu CD, Deng X, Huang JB, Wang XQ, Xiao Y. Autosomal recessive 333 base pair interleukin 10 receptor alpha subunit deletion in very early-onset inflammatory bowel disease. World J Gastroenterol 2021; 27(44): 7705-7715 [PMID: 34908808 DOI: 10.3748/wjg.v27.i44.7705] [Reference Citation Analysis]
187 Sifuentes-Dominguez L, Patel AS. Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future. F1000Res 2016;5:F1000 Faculty Rev-240. [PMID: 26973787 DOI: 10.12688/f1000research.7440.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
189 Kelsen JR, Conrad MA, Dawany N, Patel T, Shraim R, Merz A, Maurer K, Sullivan KE, Devoto M. The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:909-18. [PMID: 31560377 DOI: 10.1093/ibd/izz214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
190 Xiao Y, Wang XQ, Yu Y, Guo Y, Xu X, Gong L, Zhou T, Li XQ, Xu CD. Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease. World J Gastroenterol 2016; 22(24): 5578-5588 [PMID: 27350736 DOI: 10.3748/wjg.v22.i24.5578] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
191 Kobayashi T, Steinbach EC, Russo SM, Matsuoka K, Nochi T, Maharshak N, Borst LB, Hostager B, Garcia-Martinez JV, Rothman PB. NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis. J Immunol. 2014;192:1918-1927. [PMID: 24442434 DOI: 10.4049/jimmunol.1301819] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
192 Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O'Shea J, Wallace GR, Gadina M, Kastner DL, Gül A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet 2010;42:698-702. [PMID: 20622878 DOI: 10.1038/ng.625] [Cited by in Crossref: 438] [Cited by in F6Publishing: 367] [Article Influence: 36.5] [Reference Citation Analysis]
193 McGonagle D, Aydin SZ, Gül A, Mahr A, Direskeneli H. 'MHC-I-opathy'-unified concept for spondyloarthritis and Behçet disease. Nat Rev Rheumatol 2015;11:731-40. [PMID: 26526644 DOI: 10.1038/nrrheum.2015.147] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 14.6] [Reference Citation Analysis]
194 Lee M, Chang EB. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues. Gastroenterology 2021;160:524-37. [PMID: 33253681 DOI: 10.1053/j.gastro.2020.09.056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
195 Bain CC, Schridde A. Origin, Differentiation, and Function of Intestinal Macrophages. Front Immunol 2018;9:2733. [PMID: 30538701 DOI: 10.3389/fimmu.2018.02733] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 20.3] [Reference Citation Analysis]
196 Dinwiddie DL, Bracken JM, Bass JA, Christenson K, Soden SE, Saunders CJ, Miller NA, Singh V, Zwick DL, Roberts CC, Dalal J, Kingsmore SF. Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing. Genomics 2013;102:442-7. [PMID: 24001973 DOI: 10.1016/j.ygeno.2013.08.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
197 Henderson C, Goldbach-Mansky R. Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals. Clin Immunol 2010;135:210-22. [PMID: 20353899 DOI: 10.1016/j.clim.2010.02.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
198 Yahfoufi N, Alsadi N, Mallet JF, Kulshreshtha G, Hincke M, Ismail N, Matar C. Immunomodulation and Intestinal Morpho-Functional Aspects of a Novel Gram-Negative Bacterium Rouxiella badensis subsp. acadiensis. Front Microbiol 2021;12:569119. [PMID: 34239502 DOI: 10.3389/fmicb.2021.569119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Yang Y, Tomkovich S, Jobin C. Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish. Inflamm Bowel Dis 2014;20:956-66. [PMID: 24577115 DOI: 10.1097/01.MIB.0000442923.85569.68] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
200 Almeida de Jesus A, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol. 2013;147:155-174. [PMID: 23711932 DOI: 10.1016/j.clim.2013.03.016] [Cited by in Crossref: 118] [Cited by in F6Publishing: 89] [Article Influence: 13.1] [Reference Citation Analysis]
201 Schey R, Dornhoff H, Baier JL, Purtak M, Opoka R, Koller AK, Atreya R, Rau TT, Daniel C, Amann K. CD101 inhibits the expansion of colitogenic T cells. Mucosal Immunol. 2016;9:1205-1217. [PMID: 26813346 DOI: 10.1038/mi.2015.139] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
202 Uhde AK, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, Floess S, Baumgärtner W, Huehn J, Beineke A. Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice. PLoS One 2016;11:e0161883. [PMID: 27611574 DOI: 10.1371/journal.pone.0161883] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
203 Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology. 2013;145:293-308. [PMID: 23751777 DOI: 10.1053/j.gastro.2013.05.050] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 19.9] [Reference Citation Analysis]
204 Zeissig S, Petersen BS, Tomczak M, Melum E, Huc-Claustre E, Dougan SK, Laerdahl JK, Stade B, Forster M, Schreiber S. Early-onset Crohn’s disease and autoimmunity associated with a variant in CTLA-4. Gut. 2014;Epub ahead of print. [PMID: 25367873 DOI: 10.1136/gutjnl-2014-308541] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 9.6] [Reference Citation Analysis]
205 Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, Ouahed J, Wilson DC, Travis SP, Turner D. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990-1007.e3. [PMID: 25058236 DOI: 10.1053/j.gastro.2014.07.023] [Cited by in Crossref: 345] [Cited by in F6Publishing: 294] [Article Influence: 43.1] [Reference Citation Analysis]
206 Wang XQ, Xiao Y, Xu X, Yu Y, Shan CY, Guo Y, Gong L, Zhou T, Gao SS, Yuan YZ, Wang XJ, Xu CD. Study of disease phenotype and its association with prognosis of paediatric inflammatory bowel disease in China. BMC Pediatr. 2018;18:229. [PMID: 30001197 DOI: 10.1186/s12887-018-1212-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
207 Oft M. Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experience. Semin Immunol 2019;44:101325. [PMID: 31706853 DOI: 10.1016/j.smim.2019.101325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
208 Marafini I, Monteleone G. Precision Medicine in Inflammatory Bowel Diseases. Front Pharmacol 2021;12:653924. [PMID: 33927628 DOI: 10.3389/fphar.2021.653924] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
209 Jakaitis BM, Denning PW. Human breast milk and the gastrointestinal innate immune system. Clin Perinatol 2014;41:423-35. [PMID: 24873841 DOI: 10.1016/j.clp.2014.02.011] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 10.6] [Reference Citation Analysis]
210 Sproat T, Payne RP, Embleton ND, Berrington J, Hambleton S. T Cells in Preterm Infants and the Influence of Milk Diet. Front Immunol 2020;11:1035. [PMID: 32582165 DOI: 10.3389/fimmu.2020.01035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
211 Sherlock ME, Griffiths AM. Medical therapy for pediatric inflammatory bowel disease. Curr Gastroenterol Rep. 2012;14:166-173. [PMID: 22350842 DOI: 10.1007/s11894-012-0249-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
212 Kominsky DJ, Campbell EL, Ehrentraut SF, Wilson KE, Kelly CJ, Glover LE, Collins CB, Bayless AJ, Saeedi B, Dobrinskikh E. IFN-γ-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia. J Immunol. 2014;192:1267-1276. [PMID: 24367025 DOI: 10.4049/jimmunol.1301757] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
213 Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S, Ganapathy V. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40:128-139. [PMID: 24412617 DOI: 10.1016/j.immuni.2013.12.007] [Cited by in Crossref: 937] [Cited by in F6Publishing: 885] [Article Influence: 117.1] [Reference Citation Analysis]
214 Ferreira IB, Pickering DA, Troy S, Croese J, Loukas A, Navarro S. Suppression of inflammation and tissue damage by a hookworm recombinant protein in experimental colitis. Clin Transl Immunology 2017;6:e157. [PMID: 29114386 DOI: 10.1038/cti.2017.42] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
215 Perng P, Lim M. Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites. Front Oncol 2015;5:153. [PMID: 26217588 DOI: 10.3389/fonc.2015.00153] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 11.6] [Reference Citation Analysis]
216 Christodoulou K, Wiskin AE, Gibson J, Tapper W, Willis C, Afzal NA, Upstill-Goddard R, Holloway JW, Simpson MA, Beattie RM. Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut. 2013;62:977-984. [PMID: 22543157 DOI: 10.1136/gutjnl-2011-301833] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 8.4] [Reference Citation Analysis]
217 Sayar E, Yucel A, Eisele B, Sayar EH, Glocker E, Yuksekkaya HA. The Ineffectiveness of Tacrolimus in an Infant With a Mutation in the IL-10 Receptor. J Clin Gastroenterol 2016;50:352-3. [PMID: 26828243 DOI: 10.1097/MCG.0000000000000480] [Reference Citation Analysis]
218 Shwin KW, Lee CR, Goldbach-Mansky R. Dermatologic Manifestations of Monogenic Autoinflammatory Diseases. Dermatol Clin 2017;35:21-38. [PMID: 27890235 DOI: 10.1016/j.det.2016.07.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
219 Bujko A, Atlasy N, Landsverk OJB, Richter L, Yaqub S, Horneland R, Øyen O, Aandahl EM, Aabakken L, Stunnenberg HG, Bækkevold ES, Jahnsen FL. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med 2018;215:441-58. [PMID: 29273642 DOI: 10.1084/jem.20170057] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 15.6] [Reference Citation Analysis]
220 Shouval DS, Biswas A, Goettel JA, McCann K, Conaway E, Redhu NS, Mascanfroni ID, Al Adham Z, Lavoie S, Ibourk M. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity. 2014;40:706-719. [PMID: 24792912 DOI: 10.1016/j.immuni.2014.03.011] [Cited by in Crossref: 316] [Cited by in F6Publishing: 287] [Article Influence: 39.5] [Reference Citation Analysis]
221 Yoon SI, Jones BC, Logsdon NJ, Harris BD, Deshpande A, Radaeva S, Halloran BA, Gao B, Walter MR. Structure and mechanism of receptor sharing by the IL-10R2 common chain. Structure 2010;18:638-48. [PMID: 20462497 DOI: 10.1016/j.str.2010.02.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
222 Denson LA. The role of the innate and adaptive immune system in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2011-20. [PMID: 23702804 DOI: 10.1097/MIB.0b013e318281f590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
223 Kotlarz D, Marquardt B, Barøy T, Lee WS, Konnikova L, Hollizeck S, Magg T, Lehle AS, Walz C, Borggraefe I, Hauck F, Bufler P, Conca R, Wall SM, Schumacher EM, Misceo D, Frengen E, Bentsen BS, Uhlig HH, Hopfner KP, Muise AM, Snapper SB, Strømme P, Klein C. Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy. Nat Genet 2018;50:344-8. [PMID: 29483653 DOI: 10.1038/s41588-018-0063-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 14.3] [Reference Citation Analysis]
224 Zeissig Y, Petersen BS, Franke A, Blumberg RS, Zeissig S. Rare phenotypes in the understanding of autoimmunity. Immunol Cell Biol 2016;94:943-8. [PMID: 27562064 DOI: 10.1038/icb.2016.76] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
225 Lennon EM, Borst LB, Edwards LL, Moeser AJ. Mast Cells Exert Anti-Inflammatory Effects in an IL10<sup>-/-</sup> Model of Spontaneous Colitis. Mediators Inflamm. 2018;2018:7817360. [PMID: 29849494 DOI: 10.1155/2018/7817360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
226 El Fassi D, Nielsen CH, Junker P, Hasselbalch HC, Hegedüs L. Systemic adverse events following rituximab therapy in patients with Graves' disease. J Endocrinol Invest 2011;34:e163-7. [PMID: 21169731 DOI: 10.3275/7411] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
227 Shah N, Kammermeier J, Elawad M, Glocker EO. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep. 2012;12:373-379. [PMID: 22890722 DOI: 10.1007/s11882-012-0286-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
228 Ślebioda TJ, Kmieć Z. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediators Inflamm 2014;2014:325129. [PMID: 25045210 DOI: 10.1155/2014/325129] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
229 Hajjar S, Nathan N, Joseph J, Mottawea W, Ariana A, Pyatibrat S, Harper ME, Alain T, Blais A, Russell RC, Sad S. Foxo3a tempers excessive glutaminolysis in activated T cells to prevent fatal gut inflammation in the murine IL-10-/- model of colitis. Cell Death Differ 2021. [PMID: 34588632 DOI: 10.1038/s41418-021-00876-y] [Reference Citation Analysis]
230 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205-217. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 662] [Cited by in F6Publishing: 604] [Article Influence: 94.6] [Reference Citation Analysis]
231 Zhang Q. Human genetics of life-threatening influenza pneumonitis. Hum Genet 2020;139:941-8. [PMID: 32025908 DOI: 10.1007/s00439-019-02108-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
232 Chen ML, Sundrud MS. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:1157-1167. [PMID: 26863267 DOI: 10.1097/mib.0000000000000714] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 11.4] [Reference Citation Analysis]
233 Horuluoglu BH, Kayraklioglu N, Tross D, Klinman D. PAM3 protects against DSS-induced colitis by altering the M2:M1 ratio. Sci Rep 2020;10:6078. [PMID: 32269253 DOI: 10.1038/s41598-020-63143-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
234 Negi S, Saini S, Tandel N, Sahu K, Mishra RPN, Tyagi RK. Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice. Cells 2021;10:1847. [PMID: 34440615 DOI: 10.3390/cells10081847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Verstockt B, Smith KG, Lee JC. Genome-wide association studies in Crohn's disease: Past, present and future. Clin Transl Immunology. 2018;7:e1001. [PMID: 29484179 DOI: 10.1002/cti2.1001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
236 Uchida AM, Boden EK, James EA, Shows DM, Konecny AJ, Lord JD. Escherichiacoli-Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn's Disease. Cell Mol Gastroenterol Hepatol 2020;10:507-26. [PMID: 32361018 DOI: 10.1016/j.jcmgh.2020.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
237 Belyayev L, Loh K, Fishbein TM, Kroemer A. The parallel paradigm between intestinal transplant inflammation and inflammatory bowel disease. Curr Opin Organ Transplant 2019;24:207-11. [PMID: 30694990 DOI: 10.1097/MOT.0000000000000615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Sandy NS, Marega LF, Bechara GD, Riccetto AGL, Bonfim C, Vilela MMDS, Ribeiro AF, Servidoni MF, Lomazi EA. Elevated IgA and IL-10 levels in very-early-onset inflammatory bowel disease secondary to IL-10 receptor deficiency. Rev Paul Pediatr 2021;40:e2020434. [PMID: 34730757 DOI: 10.1590/1984-0462/2022/40/2020434] [Reference Citation Analysis]
239 Shouval DS, Biswas A, Kang YH, Griffith AE, Konnikova L, Mascanfroni ID, Redhu NS, Frei SM, Field M, Doty AL, Goldsmith JD, Bhan AK, Loizides A, Weiss B, Yerushalmi B, Yanagi T, Lui X, Quintana FJ, Muise AM, Klein C, Horwitz BH, Glover SC, Bousvaros A, Snapper SB. Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. Gastroenterology 2016;151:1100-4. [PMID: 27693323 DOI: 10.1053/j.gastro.2016.08.055] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 16.3] [Reference Citation Analysis]
240 Mukhopadhyay S, Heinz E, Porreca I, Alasoo K, Yeung A, Yang HT, Schwerd T, Forbester JL, Hale C, Agu CA, Choi YH, Rodrigues J, Capitani M, Jostins-Dean L, Thomas DC, Travis S, Gaffney D, Skarnes WC, Thomson N, Uhlig HH, Dougan G, Powrie F. Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2. J Exp Med 2020;217:e20180649. [PMID: 31819956 DOI: 10.1084/jem.20180649] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
241 Ma CS. Human T Follicular Helper Cells in Primary Immunodeficiency: Quality Just as Important as Quantity. J Clin Immunol 2016;36 Suppl 1:40-7. [PMID: 26961358 DOI: 10.1007/s10875-016-0257-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
242 Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity. 2012;36:515-528. [PMID: 22520845 DOI: 10.1016/j.immuni.2012.03.016] [Cited by in Crossref: 210] [Cited by in F6Publishing: 195] [Article Influence: 21.0] [Reference Citation Analysis]
243 Bollyky PL, Vernon RB, Falk BA, Preisinger A, Gooden MD, Nepom GT, Gebe JA. IL-10 induction from implants delivering pancreatic islets and hyaluronan. J Diabetes Res 2013;2013:342479. [PMID: 23971054 DOI: 10.1155/2013/342479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
244 Jamontt J, Petit S, Clark N, Parkinson SJ, Smith P. Nucleotide-binding oligomerization domain 2 signaling promotes hyperresponsive macrophages and colitis in IL-10-deficient mice. J Immunol. 2013;190:2948-2958. [PMID: 23396949 DOI: 10.4049/jimmunol.1201332] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
245 Amoroso C, Perillo F, Strati F, Fantini MC, Caprioli F, Facciotti F. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation. Cells 2020;9:E1234. [PMID: 32429359 DOI: 10.3390/cells9051234] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
246 Huber S, Gagliani N, Esplugues E, O’Connor W, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY. Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity. 2011;34:554-565. [PMID: 21511184 DOI: 10.1016/j.immuni.2011.01.020] [Cited by in Crossref: 396] [Cited by in F6Publishing: 387] [Article Influence: 36.0] [Reference Citation Analysis]
247 Hourigan SK, Oliva-Hemker M, Hutfless S. The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Dig Dis Sci. 2014;59:2222-2227. [PMID: 24788321 DOI: 10.1007/s10620-014-3169-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
248 Afzali A, Katz S. Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD. Curr Treat Options Gastroenterol 2018;16:289-305. [PMID: 30006766 DOI: 10.1007/s11938-018-0188-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
249 Magg T, Shcherbina A, Arslan D, Desai MM, Wall S, Mitsialis V, Conca R, Unal E, Karacabey N, Mukhina A, Rodina Y, Taur PD, Illig D, Marquardt B, Hollizeck S, Jeske T, Gothe F, Schober T, Rohlfs M, Koletzko S, Lurz E, Muise AM, Snapper SB, Hauck F, Klein C, Kotlarz D. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1788-95. [PMID: 31115454 DOI: 10.1093/ibd/izz103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
250 Walter MR. The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol 2014;380:191-212. [PMID: 25004819 DOI: 10.1007/978-3-662-43492-5_9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
251 Chiaranunt P, Tai SL, Ngai L, Mortha A. Beyond Immunity: Underappreciated Functions of Intestinal Macrophages. Front Immunol 2021;12:749708. [PMID: 34650568 DOI: 10.3389/fimmu.2021.749708] [Reference Citation Analysis]
252 Costello ME, Elewaut D, Kenna TJ, Brown MA. Microbes, the gut and ankylosing spondylitis. Arthritis Res Ther 2013;15:214. [PMID: 23750937 DOI: 10.1186/ar4228] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
253 Chung H, Green PHR, Wang TC, Kong XF. Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence. J Inflamm Res 2021;14:5187-200. [PMID: 34675597 DOI: 10.2147/JIR.S280953] [Reference Citation Analysis]
254 Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, Dunne WM, Allen PM, Stappenbeck TS. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe. 2011;9:390-403. [PMID: 21575910 DOI: 10.1016/j.chom.2011.04.009.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
255 Kaser A, Zeissig S, Blumberg RS. Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Dig Dis. 2010;28:395-405. [PMID: 20926863 DOI: 10.1159/000320393] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
256 Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, Anderson CA, Bis JC, Bumpstead S, Ellinghaus D, Festen EM, Georges M, Green T, Haritunians T, Jostins L, Latiano A, Mathew CG, Montgomery GW, Prescott NJ, Raychaudhuri S, Rotter JI, Schumm P, Sharma Y, Simms LA, Taylor KD, Whiteman D, Wijmenga C, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Cohen A, Colombel JF, Cottone M, Stronati L, Denson T, De Vos M, D'Inca R, Dubinsky M, Edwards C, Florin T, Franchimont D, Gearry R, Glas J, Van Gossum A, Guthery SL, Halfvarson J, Verspaget HW, Hugot JP, Karban A, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, Mowat C, Newman W, Panés J, Phillips A, Proctor DD, Regueiro M, Russell R, Rutgeerts P, Sanderson J, Sans M, Seibold F, Steinhart AH, Stokkers PC, Torkvist L, Kullak-Ublick G, Wilson D, Walters T, Targan SR, Brant SR, Rioux JD, D'Amato M, Weersma RK, Kugathasan S, Griffiths AM, Mansfield JC, Vermeire S, Duerr RH, Silverberg MS, Satsangi J, Schreiber S, Cho JH, Annese V, Hakonarson H, Daly MJ, Parkes M. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-25. [PMID: 21102463 DOI: 10.1038/ng.717] [Cited by in Crossref: 1784] [Cited by in F6Publishing: 1674] [Article Influence: 148.7] [Reference Citation Analysis]
257 Li J, Shouval DS, Doty AL, Snapper SB, Glover SC. Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakin Treatment Suggests Further Mechanism for Mucosal Healing. J Clin Immunol 2017;37:104-7. [PMID: 28064389 DOI: 10.1007/s10875-016-0365-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
258 Matsumoto H, Haga K, Ohno I, Hiraoka K, Kimura T, Hermann K, Kasahara N, Anton P, McGowan I. Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis. BMC Gastroenterol 2014;14:68. [PMID: 24712338 DOI: 10.1186/1471-230X-14-68] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
259 Elson CO, Cong Y. Host-microbiota interactions in inflammatory bowel disease. Gut Microbes 2012;3:332-44. [PMID: 22572873 DOI: 10.4161/gmic.20228] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
260 Manry J, Laval G, Patin E, Fornarino S, Itan Y, Fumagalli M, Sironi M, Tichit M, Bouchier C, Casanova JL, Barreiro LB, Quintana-Murci L. Evolutionary genetic dissection of human interferons. J Exp Med 2011;208:2747-59. [PMID: 22162829 DOI: 10.1084/jem.20111680] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 10.6] [Reference Citation Analysis]
261 Li Z, Rotival M, Patin E, Michel F, Pellegrini S. Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage. PLoS One 2020;15:e0225289. [PMID: 31961910 DOI: 10.1371/journal.pone.0225289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
262 Hale LP. Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis. PLoS One 2020;15:e0239295. [PMID: 32941525 DOI: 10.1371/journal.pone.0239295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
263 Ilott NE, Bollrath J, Danne C, Schiering C, Shale M, Adelmann K, Krausgruber T, Heger A, Sims D, Powrie F. Defining the microbial transcriptional response to colitis through integrated host and microbiome profiling. ISME J 2016;10:2389-404. [PMID: 27003245 DOI: 10.1038/ismej.2016.40] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
264 Sanjabi S, Oh SA, Li MO. Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection. Cold Spring Harb Perspect Biol 2017;9:a022236. [PMID: 28108486 DOI: 10.1101/cshperspect.a022236] [Cited by in Crossref: 174] [Cited by in F6Publishing: 161] [Article Influence: 34.8] [Reference Citation Analysis]
265 Sim WH, Wagner J, Cameron DJ, Catto-Smith AG, Bishop RF, Kirkwood CD. Expression profile of genes involved in pathogenesis of pediatric Crohn’s disease. J Gastroenterol Hepatol. 2012;27:1083-1093. [PMID: 22098497 DOI: 10.1111/j.1440-1746.2011.06973.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
266 Lipinski S, Petersen BS, Barann M, Piecyk A, Tran F, Mayr G, Jentzsch M, Aden K, Stengel ST, Klostermeier UC, Sheth V, Ellinghaus D, Rausch T, Korbel JO, Nothnagel M, Krawczak M, Gilissen C, Veltman JA, Forster M, Forster P, Lee CC, Fritscher-Ravens A, Schreiber S, Franke A, Rosenstiel P. Missense variants in NOX1 and p22phox in a case of very-early-onset inflammatory bowel disease are functionally linked to NOD2. Cold Spring Harb Mol Case Stud 2019;5:a002428. [PMID: 30709874 DOI: 10.1101/mcs.a002428] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
267 Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, Dunne WM Jr, Allen PM, Stappenbeck TS. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe. 2011;9:390-403. [PMID: 21575910 DOI: 10.1016/j.chom.2011.04.009] [Cited by in Crossref: 295] [Cited by in F6Publishing: 283] [Article Influence: 26.8] [Reference Citation Analysis]
268 Ruder B, Becker C. At the Forefront of the Mucosal Barrier: The Role of Macrophages in the Intestine. Cells 2020;9:E2162. [PMID: 32987848 DOI: 10.3390/cells9102162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
269 Karaca NE, Aksu G, Ulusoy E, Aksoylar S, Gozmen S, Genel F, Akarcan S, Gulez N, Hirschmugl T, Kansoy S, Boztug K, Kutukculer N. Early Diagnosis and Hematopoietic Stem Cell Transplantation for IL10R Deficiency Leading to Very Early-Onset Inflammatory Bowel Disease Are Essential in Familial Cases. Case Reports Immunol 2016;2016:5459029. [PMID: 27699073 DOI: 10.1155/2016/5459029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
270 Milner JD, Holland SM. The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol 2013;13:635-48. [PMID: 23887241 DOI: 10.1038/nri3493] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 8.2] [Reference Citation Analysis]
271 Xiao P, Zhang H, Zhang Y, Zheng M, Liu R, Zhao Y, Zhang X, Cheng H, Cao Q, Ke Y. Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10. J Exp Med 2019;216:337-49. [PMID: 30610104 DOI: 10.1084/jem.20181198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
272 Bernshtein B, Curato C, Ioannou M, Thaiss CA, Gross-Vered M, Kolesnikov M, Wang Q, David E, Chappell-Maor L, Harmelin A, Elinav E, Thakker P, Papayannopoulos V, Jung S. IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response. Sci Immunol 2019;4:eaau6571. [PMID: 31201258 DOI: 10.1126/sciimmunol.aau6571] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
273 Ray A, Dittel BN. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology 2015;146:359-68. [PMID: 26211540 DOI: 10.1111/imm.12511] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
274 Amit I, Winter DR, Jung S. The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis. Nat Immunol 2016;17:18-25. [PMID: 26681458 DOI: 10.1038/ni.3325] [Cited by in Crossref: 232] [Cited by in F6Publishing: 214] [Article Influence: 38.7] [Reference Citation Analysis]
275 Gasparetto M, Guariso G, Pozza LV, Ross A, Heuschkel R, Zilbauer M. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy. BMC Gastroenterol 2016;16:35. [PMID: 26976427 DOI: 10.1186/s12876-016-0455-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
276 Chen YF, Xia Y. Convergent perturbation of the human domain-resolved interactome by viruses and mutations inducing similar disease phenotypes. PLoS Comput Biol 2019;15:e1006762. [PMID: 30759076 DOI: 10.1371/journal.pcbi.1006762] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
277 Finsterbusch M, Khare V, Campregher C, Evstatiev R, Gasche C. An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation. Genes Immun 2011;12:575-81. [PMID: 21654841 DOI: 10.1038/gene.2011.12] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
278 McGovern DP, Kugathasan S, Cho JH. Genetics of Inflammatory Bowel Diseases. Gastroenterology 2015;149:1163-1176.e2. [PMID: 26255561 DOI: 10.1053/j.gastro.2015.08.001] [Cited by in Crossref: 196] [Cited by in F6Publishing: 178] [Article Influence: 28.0] [Reference Citation Analysis]
279 Hünerwadel A, Fagagnini S, Rogler G, Lutz C, Jaeger SU, Mamie C, Weder B, Ruiz PA, Hausmann M. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis. Sci Rep 2018;8:15182. [PMID: 30315190 DOI: 10.1038/s41598-018-33452-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
280 Pan D, Kenway-Lynch CS, Lala W, Veazey RS, Lackner AA, Das A, Pahar B. Lack of interleukin-10-mediated anti-inflammatory signals and upregulated interferon gamma production are linked to increased intestinal epithelial cell apoptosis in pathogenic simian immunodeficiency virus infection. J Virol 2014;88:13015-28. [PMID: 25165117 DOI: 10.1128/JVI.01757-14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
281 Fang YH, Luo YY, Yu JD, Lou JG, Chen J. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China. World J Gastroenterol 2018; 24(9): 1035-1045 [PMID: 29531467 DOI: 10.3748/wjg.v24.i9.1035] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
282 Wang MH, Fiocchi C, Ripke S, Zhu X, Duerr RH, Achkar JP. A novel approach to detect cumulative genetic effects and genetic interactions in Crohn's disease. Inflamm Bowel Dis 2013;19:1799-808. [PMID: 23598818 DOI: 10.1097/MIB.0b013e31828706a0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
283 Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268-1273. [PMID: 22674334 DOI: 10.1126/science.1223490] [Cited by in Crossref: 2300] [Cited by in F6Publishing: 2090] [Article Influence: 230.0] [Reference Citation Analysis]
284 Muise AM, Xu W, Guo CH, Walters TD, Wolters VM, Fattouh R, Lam GY, Hu P, Murchie R, Sherlock M. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut. 2012;61:1028-1035. [PMID: 21900546 DOI: 10.1136/gutjnl-2011-300078] [Cited by in Crossref: 119] [Cited by in F6Publishing: 114] [Article Influence: 10.8] [Reference Citation Analysis]
285 Recher M, Fried AJ, Massaad MJ, Kim HY, Rizzini M, Frugoni F, Walter JE, Mathew D, Eibel H, Hess C, Giliani S, Umetsu DT, Notarangelo LD, Geha RS. Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia. Clin Immunol 2013;146:84-9. [PMID: 23280491 DOI: 10.1016/j.clim.2012.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
286 Rabizadeh S, Dubinsky M. Update in pediatric inflammatory bowel disease. Rheum Dis Clin North Am 2013;39:789-99. [PMID: 24182855 DOI: 10.1016/j.rdc.2013.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
287 Li B, Gurung P, Malireddi RK, Vogel P, Kanneganti TD, Geiger TL. IL-10 engages macrophages to shift Th17 cytokine dependency and pathogenicity during T-cell-mediated colitis. Nat Commun. 2015;6:6131. [PMID: 25607885 DOI: 10.1038/ncomms7131] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
288 Griffin DO, Rothstein TL. Human "orchestrator" CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity. Mol Med 2012;18:1003-8. [PMID: 22634719 DOI: 10.2119/molmed.2012.00203] [Cited by in Crossref: 48] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
289 Dubois-Camacho K, Ottum PA, Franco-Muñoz D, De la Fuente M, Torres-Riquelme A, Díaz-Jiménez D, Olivares-Morales M, Astudillo G, Quera R, Hermoso MA. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology. World J Gastroenterol 2017; 23(36): 6628-6638 [PMID: 29085208 DOI: 10.3748/wjg.v23.i36.6628] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
290 Leonard WJ, Wan CK. IL-21 Signaling in Immunity. F1000Res 2016;5:F1000 Faculty Rev-224. [PMID: 26966515 DOI: 10.12688/f1000research.7634.1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 9.7] [Reference Citation Analysis]
291 Tindemans I, Joosse ME, Samsom JN. Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD. Cells 2020;9:E110. [PMID: 31906479 DOI: 10.3390/cells9010110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
292 Liu X, Alli R, Steeves M, Nguyen P, Vogel P, Geiger TL. The T cell response to IL-10 alters cellular dynamics and paradoxically promotes central nervous system autoimmunity. J Immunol 2012;189:669-78. [PMID: 22711892 DOI: 10.4049/jimmunol.1200607] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
293 Lai HY, Brooks SA, Craver BM, Morse SJ, Nguyen TK, Haghighi N, Garbati MR, Fleischman AG. Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm. Blood Adv 2019;3:122-31. [PMID: 30647074 DOI: 10.1182/bloodadvances.2018026450] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
294 Moran CJ, Klein C, Muise AM, Snapper SB. Very early-onset inflammatory bowel disease: gaining insight through focused discovery. Inflamm Bowel Dis. 2015;21:1166-1175. [PMID: 25895007 DOI: 10.1097/mib.0000000000000329] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
295 Ramos GP, Papadakis KA. Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc. 2019;94:155-165. [PMID: 30611442 DOI: 10.1016/j.mayocp.2018.09.013] [Cited by in Crossref: 141] [Cited by in F6Publishing: 131] [Article Influence: 47.0] [Reference Citation Analysis]
296 Blum AM, Hang L, Setiawan T, Urban JP, Stoyanoff KM, Leung J, Weinstock JV. Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J Immunol. 2012;189:2512-2520. [PMID: 22844110 DOI: 10.4049/jimmunol.1102892] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
297 Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of  Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis 2021;27:295-302. [PMID: 32386060 DOI: 10.1093/ibd/izaa080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
298 Prussin C, Yin Y, Upadhyaya B. T(H)2 heterogeneity: Does function follow form? J Allergy Clin Immunol 2010;126:1094-8. [PMID: 20951419 DOI: 10.1016/j.jaci.2010.08.031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
299 Samiea A, Yoon JSJ, Cheung ST, Chamberlain TC, Mui AL. Interleukin-10 contributes to PGE2 signalling through upregulation of EP4 via SHIP1 and STAT3. PLoS One 2020;15:e0230427. [PMID: 32240179 DOI: 10.1371/journal.pone.0230427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
300 Joosse ME, Charbit-Henrion F, Boisgard R, Raatgeep RHC, Lindenbergh-Kortleve DJ, Costes LMM, Nugteren S, Guegan N, Parlato M, Veenbergen S, Malan V, Nowak JK, Hollink IHIM, Mearin ML, Escher JC, Cerf-Bensussan N, Samsom JN. Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis. Mucosal Immunol 2021;14:1172-82. [PMID: 34226674 DOI: 10.1038/s41385-021-00423-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Lv H, Jiang Y, Li J, Zhang M, Shang Z, Zheng J, Wu X, Liu P, Zhang R, Yu H. Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease. Mol Biol Rep 2014;41:1299-310. [PMID: 24407599 DOI: 10.1007/s11033-013-2975-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
302 Cutler DJ, Zwick ME, Okou DT, Prahalad S, Walters T, Guthery SL, Dubinsky M, Baldassano R, Crandall WV, Rosh J, Markowitz J, Stephens M, Kellermayer R, Pfefferkorn M, Heyman MB, LeLeiko N, Mack D, Moulton D, Kappelman MD, Kumar A, Prince J, Bose P, Mondal K, Ramachandran D, Bohnsack JF, Griffiths AM, Haberman Y, Essers J, Thompson SD, Aronow B, Keljo DJ, Hyams JS, Denson LA, Kugathasan S; PRO-KIIDS Research Group. Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping. PLoS One 2015;10:e0128074. [PMID: 26098103 DOI: 10.1371/journal.pone.0128074] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
303 Lyons JJ, Milner JD. Primary atopic disorders. J Exp Med 2018;215:1009-22. [PMID: 29549114 DOI: 10.1084/jem.20172306] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
304 Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066-2078. [PMID: 19923578 DOI: 10.1056/nejmra0804647] [Cited by in Crossref: 1689] [Cited by in F6Publishing: 900] [Article Influence: 129.9] [Reference Citation Analysis]
305 Aslibekyan S, Kabagambe EK, Irvin MR, Straka RJ, Borecki IB, Tiwari HK, Tsai MY, Hopkins PN, Shen J, Lai CQ, Ordovas JM, Arnett DK. A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. Pharmacogenet Genomics 2012;22:191-7. [PMID: 22228203 DOI: 10.1097/FPC.0b013e32834fdd41] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
306 Wilson MS, Ramalingam TR, Rivollier A, Shenderov K, Mentink-Kane MM, Madala SK, Cheever AW, Artis D, Kelsall BL, Wynn TA. Colitis and intestinal inflammation in IL10-/- mice results from IL-13Rα2-mediated attenuation of IL-13 activity. Gastroenterology. 2011;140:254-264. [PMID: 20951137 DOI: 10.1053/j.gastro.2010.09.047] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
307 Dara N, Nemati S, Teimourian S, Imanzadeh F, Hosseini A, Tajalli S, Sayyari AA, Najafi A, Rohani P, Khatami K, Motevaseli E, de Boer M, Kuijpers TW. Diagnostic Challenges in the Early Onset of Inflammatory Bowel Disease: A Case Report. Int J Mol Cell Med 2018;7:251-7. [PMID: 31516885 DOI: 10.22088/IJMCM.BUMS.7.4.251] [Reference Citation Analysis]
308 Neves JF, Doffinger R, Barcena-Morales G, Martins C, Papapietro O, Plagnol V, Curtis J, Martins M, Kumararatne D, Cordeiro AI, Neves C, Borrego LM, Katan M, Nejentsev S. Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa. Front Immunol 2018;9:2863. [PMID: 30619256 DOI: 10.3389/fimmu.2018.02863] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
309 Pellerin L, Jenks JA, Bégin P, Bacchetta R, Nadeau KC. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 2014;58:358-68. [PMID: 24781194 DOI: 10.1007/s12026-014-8512-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 9.3] [Reference Citation Analysis]
310 Moghaddas F, Masters SL. The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders. Clin Sci (Lond) 2018;132:1901-24. [PMID: 30185613 DOI: 10.1042/CS20171498] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
311 Sun M, Wu W, Chen L, Yang W, Huang X, Ma C, Chen F, Xiao Y, Zhao Y, Ma C, Yao S, Carpio VH, Dann SM, Zhao Q, Liu Z, Cong Y. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun. 2018;9:3555. [PMID: 30177845 DOI: 10.1038/s41467-018-05901-2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 125] [Article Influence: 31.0] [Reference Citation Analysis]
312 Hoffmann D, Sens J, Brennig S, Brand D, Philipp F, Vollmer Barbosa P, Kuehle J, Steinemann D, Lenz D, Buchegger T, Morgan M, Falk CS, Klein C, Lachmann N, Schambach A. Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages. J Pers Med 2021;11:221. [PMID: 33804706 DOI: 10.3390/jpm11030221] [Reference Citation Analysis]
313 Ferré EMN, Schmitt MM, Lionakis MS. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Front Pediatr 2021;9:723532. [PMID: 34790633 DOI: 10.3389/fped.2021.723532] [Reference Citation Analysis]
314 Principi M, Barone M, Pricci M, De Tullio N, Losurdo G, Ierardi E, Di Leo A. Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role? World J Gastroenterol 2014; 20(33): 11496-11504 [PMID: 25206257 DOI: 10.3748/wjg.v20.i33.11496] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
315 Liu L, Dong Y, Ye M, Jin S, Yang J, Joosse ME, Sun Y, Zhang J, Lazarev M, Brant SR, Safar B, Marohn M, Mezey E, Li X. The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans. J Crohns Colitis. 2017;11:737-750. [PMID: 27993998 DOI: 10.1093/ecco-jcc/jjw219] [Cited by in Crossref: 23] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
316 Mishima Y, Sartor RB. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. J Gastroenterol 2020;55:4-14. [PMID: 31482438 DOI: 10.1007/s00535-019-01618-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
317 Nishida A, Lau CW, Zhang M, Andoh A, Shi HN, Mizoguchi E, Mizoguchi A. The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice. Gastroenterology. 2012;142:865-874.e2. [PMID: 22202458 DOI: 10.1053/j.gastro.2011.12.036] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
318 Kirino Y, Nakajima H. Clinical and Genetic Aspects of Behçet's Disease in Japan. Intern Med 2019;58:1199-207. [PMID: 30626832 DOI: 10.2169/internalmedicine.2035-18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
319 Cho MJ, Ellebrecht CT, Payne AS. The dual nature of interleukin-10 in pemphigus vulgaris. Cytokine 2015;73:335-41. [PMID: 25464924 DOI: 10.1016/j.cyto.2014.11.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
320 Mountford S, Ringleb A, Schwaiger R, Mayr D, Kobold S, Dinarello CA, Bufler P. Interleukin-37 Inhibits Colon Carcinogensis During Chronic Colitis. Front Immunol 2019;10:2632. [PMID: 31781119 DOI: 10.3389/fimmu.2019.02632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
321 Baran M, Çağan Appak Y, Garipcin P, Demirçelik Y, Pala EE, Özyilmaz B, Karakoyun M, Ergün O. The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula. Arch Rheumatol 2018;33:473-7. [PMID: 30874249 DOI: 10.5606/ArchRheumatol.2018.6741] [Reference Citation Analysis]
322 Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol 2010;28:4045-51. [PMID: 20644090 DOI: 10.1200/JCO.2010.27.9992] [Cited by in Crossref: 115] [Cited by in F6Publishing: 88] [Article Influence: 9.6] [Reference Citation Analysis]
323 Torow N, Marsland BJ, Hornef MW, Gollwitzer ES. Neonatal mucosal immunology. Mucosal Immunol 2017;10:5-17. [PMID: 27649929 DOI: 10.1038/mi.2016.81] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 10.5] [Reference Citation Analysis]
324 Arnold IC, Müller A. Helicobacter pylori: Does Gastritis Prevent Colitis? Inflamm Intest Dis 2016;1:102-12. [PMID: 29922665 DOI: 10.1159/000445985] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
325 Gaba A, Grivennikov SI, Do MV, Stumpo DJ, Blackshear PJ, Karin M. Cutting edge: IL-10-mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production. J Immunol 2012;189:2089-93. [PMID: 22865915 DOI: 10.4049/jimmunol.1201126] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
326 Fu SH, Chien MW, Hsu CY, Liu YW, Sytwu HK. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E3379. [PMID: 32403220 DOI: 10.3390/ijms21093379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
327 Barnig C, Bezema T, Calder PC, Charloux A, Frossard N, Garssen J, Haworth O, Dilevskaya K, Levi-Schaffer F, Lonsdorfer E, Wauben M, Kraneveld AD, Te Velde AA. Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease. Front Immunol 2019;10:1699. [PMID: 31396220 DOI: 10.3389/fimmu.2019.01699] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
328 Liu TC, Stappenbeck TS. Genetics and Pathogenesis of Inflammatory Bowel Disease. Annu Rev Pathol. 2016;11:127-148. [PMID: 26907531 DOI: 10.1146/annurev-pathol-012615-044152] [Cited by in Crossref: 127] [Cited by in F6Publishing: 117] [Article Influence: 21.2] [Reference Citation Analysis]
329 Mizoguchi A. Healing of intestinal inflammation by IL-22. Inflamm Bowel Dis. 2012;18:1777-1784. [PMID: 22359410 DOI: 10.1002/ibd.22929] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 8.3] [Reference Citation Analysis]
330 Lee WI, Chen CC, Jaing TH, Ou LS, Hsueh C, Huang JL. A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases. Sci Rep 2017;7:3669. [PMID: 28623282 DOI: 10.1038/s41598-017-03967-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
331 Caprioli F, Caruso R, Sarra M, Pallone F, Monteleone G. Disruption of inflammatory signals by cytokine-targeted therapies for inflammatory bowel diseases. Br J Pharmacol 2012;165:820-8. [PMID: 21806600 DOI: 10.1111/j.1476-5381.2011.01614.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
332 Punit S, Dubé PE, Liu CY, Girish N, Washington MK, Polk DB. Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis. Gastroenterology 2015;149:993-1005.e2. [PMID: 26072395 DOI: 10.1053/j.gastro.2015.06.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
333 Isidro RA, Appleyard CB. Colonic macrophage polarization in homeostasis, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol. 2016;311:G59-G73. [PMID: 27229123 DOI: 10.1152/ajpgi.00123.2016] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 14.8] [Reference Citation Analysis]
334 Hayashi S, Hamada T, Zinsou DGA, Oshiro M, Itoi K, Yamamoto T, Kadowaki M. PI3K p85α Subunit-deficient Macrophages Protect Mice from Acute Colitis due to the Enhancement of IL-10 Production. Sci Rep 2017;7:6187. [PMID: 28733636 DOI: 10.1038/s41598-017-06464-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
335 Erdős M, Tsumura M, Kállai J, Lányi Á, Nyul Z, Balázs G, Okada S, Maródi L. Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype. Clin Exp Immunol 2021;205:354-62. [PMID: 34050927 DOI: 10.1111/cei.13625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
336 Biasi F, Leonarduzzi G, Oteiza PI, Poli G. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal. 2013;19:1711-1747. [PMID: 23305298 DOI: 10.1089/ars.2012.4530] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 13.1] [Reference Citation Analysis]
337 Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of treg-mediated T cell suppression. Front Immunol 2012;3:51. [PMID: 22566933 DOI: 10.3389/fimmu.2012.00051] [Cited by in Crossref: 263] [Cited by in F6Publishing: 304] [Article Influence: 26.3] [Reference Citation Analysis]
338 Martínez-Montiel MDP, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1211-1227 [PMID: 24574796 DOI: 10.3748/wjg.v20.i5.1211] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
339 Glocker E, Grimbacher B. Inflammatory bowel disease: is it a primary immunodeficiency? Cell Mol Life Sci. 2012;69:41-48. [PMID: 21997382 DOI: 10.1007/s00018-011-0837-9] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
340 Segal AW. Making sense of the cause of Crohn's - a new look at an old disease. F1000Res. 2016;5:2510. [PMID: 28105308 DOI: 10.12688/f1000research.9699.2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
341 Victor JM, Debret G, Lesne A, Pascoe L, Carrivain P, Wainrib G, Hugot JP. Network Modeling of Crohn's Disease Incidence. PLoS One 2016;11:e0156138. [PMID: 27309539 DOI: 10.1371/journal.pone.0156138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
342 Kubo M, Motomura Y. Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells. Front Immunol 2012;3:275. [PMID: 22969768 DOI: 10.3389/fimmu.2012.00275] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
343 Nadya NA, Tezuka H, Ohteki T, Matsuda S, Azuma M, Nagai S. PI3K-Akt pathway enhances the differentiation of interleukin-27-induced type 1 regulatory T cells. Immunology 2017;152:507-16. [PMID: 28685820 DOI: 10.1111/imm.12789] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
344 Witzel M, Petersheim D, Fan Y, Bahrami E, Racek T, Rohlfs M, Puchałka J, Mertes C, Gagneur J, Ziegenhain C, Enard W, Stray-Pedersen A, Arkwright PD, Abboud MR, Pazhakh V, Lieschke GJ, Krawitz PM, Dahlhoff M, Schneider MR, Wolf E, Horny HP, Schmidt H, Schäffer AA, Klein C. Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes. Nat Genet 2017;49:742-52. [PMID: 28369036 DOI: 10.1038/ng.3833] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
345 Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, Field M, Grushkin-Lerner L, Pai SY, Bousvaros A, Cho J, Argmann C, Schadt E, Mcgovern DPB, Mokry M, Nieuwenhuis E, Clevers H, Powrie F, Uhlig H, Klein C, Muise A, Dubinsky M, Snapper SB. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis 2020;26:820-42. [PMID: 31833544 DOI: 10.1093/ibd/izz259] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
346 Aschenbrenner D, Foglierini M, Jarrossay D, Hu D, Weiner HL, Kuchroo VK, Lanzavecchia A, Notarbartolo S, Sallusto F. An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells. Nat Immunol 2018;19:1126-36. [PMID: 30201991 DOI: 10.1038/s41590-018-0200-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 10.8] [Reference Citation Analysis]
347 Castro-Dopico T, Clatworthy MR. IgG and Fcγ Receptors in Intestinal Immunity and Inflammation. Front Immunol 2019;10:805. [PMID: 31031776 DOI: 10.3389/fimmu.2019.00805] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
348 Moutsopoulos NM, Lionakis MS, Hajishengallis G. Inborn errors in immunity: unique natural models to dissect oral immunity. J Dent Res 2015;94:753-8. [PMID: 25900229 DOI: 10.1177/0022034515583533] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
349 Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol. 2015;50:495-507. [PMID: 25808229 DOI: 10.1007/s00535-015-1064-1] [Cited by in Crossref: 124] [Cited by in F6Publishing: 121] [Article Influence: 17.7] [Reference Citation Analysis]
350 Elcombe SE, Naqvi S, Van Den Bosch MW, MacKenzie KF, Cianfanelli F, Brown GD, Arthur JS. Dectin-1 regulates IL-10 production via a MSK1/2 and CREB dependent pathway and promotes the induction of regulatory macrophage markers. PLoS One. 2013;8:e60086. [PMID: 23533666 DOI: 10.1371/journal.pone.0060086] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
351 Krause P, Morris V, Greenbaum JA, Park Y, Bjoerheden U, Mikulski Z, Muffley T, Shui JW, Kim G, Cheroutre H, Liu YC, Peters B, Kronenberg M, Murai M. IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis. Nat Commun. 2015;6:7055. [PMID: 25959063 DOI: 10.1038/ncomms8055] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 9.1] [Reference Citation Analysis]
352 Pizarro TT, Pastorelli L, Bamias G, Garg RR, Reuter BK, Mercado JR, Chieppa M, Arseneau KO, Ley K, Cominelli F. SAMP1/YitFc mouse strain: a spontaneous model of Crohn’s disease-like ileitis. Inflamm Bowel Dis. 2011;17:2566-2584. [PMID: 21557393 DOI: 10.1002/ibd.21638] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 9.0] [Reference Citation Analysis]
353 Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317. [PMID: 21677747 DOI: 10.1038/nature] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
354 Aschenbrenner D, Quaranta M, Banerjee S, Ilott N, Jansen J, Steere B, Chen YH, Ho S, Cox K, Arancibia-Cárcamo CV, Coles M, Gaffney E, Travis SP, Denson L, Kugathasan S, Schmitz J, Powrie F, Sansom SN, Uhlig HH. Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut 2021;70:1023-36. [PMID: 33037057 DOI: 10.1136/gutjnl-2020-321731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
355 Pelaseyed T, Hansson GC. Membrane mucins of the intestine at a glance. J Cell Sci 2020;133:jcs240929. [PMID: 32169835 DOI: 10.1242/jcs.240929] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
356 Lee WI, Huang JL, Lin SJ, Yeh KW, Chen LC, Ou LS, Yao TC, Jaing TH, Shih YF, Wu CY. Lower T Regulatory and Th17 Cell Populations Predicted by RT-PCR-Amplified FOXP3 and RORγt Genes Are Not Rare in Patients With Primary Immunodeficiency Diseases. Front Immunol 2020;11:1111. [PMID: 32670274 DOI: 10.3389/fimmu.2020.01111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
357 Rosen MJ, Dhawan A, Saeed SA. Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr. 2015;169:1053-1060. [PMID: 26414706 DOI: 10.1001/jamapediatrics.2015.1982] [Cited by in Crossref: 192] [Cited by in F6Publishing: 165] [Article Influence: 32.0] [Reference Citation Analysis]
358 Shim JO. Recent advance in very early-onset inflammatory bowel disease. Intest Res 2019;17:9-16. [PMID: 30419637 DOI: 10.5217/ir.2018.00130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
359 Day AS, Ledder O, Leach ST, Lemberg DA. Crohn’s and colitis in children and adolescents. World J Gastroenterol 2012; 18(41): 5862-5869 [PMID: 23139601 DOI: 10.3748/wjg.v18.i41.5862] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
360 Mizoguchi E, Low D, Ezaki Y, Okada T. Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models. Intest Res. 2020;18:151-167. [PMID: 32326669 DOI: 10.5217/ir.2019.09154] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
361 Sheikh SZ, Plevy SE. The role of the macrophage in sentinel responses in intestinal immunity. Curr Opin Gastroenterol. 2010;26:578-582. [PMID: 20717022 DOI: 10.1097/mog.0b013e32833d4b71] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
362 Dhillon SS, Mastropaolo LA, Murchie R, Griffiths C, Thöni C, Elkadri A, Xu W, Mack A, Walters T, Guo C, Mack D, Huynh H, Baksh S, Silverberg MS, Brumell JH, Snapper SB, Muise AM. Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease. Clin Transl Gastroenterol 2014;5:e46. [PMID: 24430113 DOI: 10.1038/ctg.2013.17] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
363 Al-Okaily F, Arfin M, Al-Rashidi S, Al-Balawi M, Al-Asmari A. Inflammation-related cytokine gene polymorphisms in Behçet's disease. J Inflamm Res 2015;8:173-80. [PMID: 26451120 DOI: 10.2147/JIR.S89283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
364 Stankovic B, Kotur N, Nikcevic G, Gasic V, Zukic B, Pavlovic S. Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications. Genes (Basel) 2021;12:1438. [PMID: 34573420 DOI: 10.3390/genes12091438] [Reference Citation Analysis]
365 Forbester JL, Lees EA, Goulding D, Forrest S, Yeung A, Speak A, Clare S, Coomber EL, Mukhopadhyay S, Kraiczy J, Schreiber F, Lawley TD, Hancock REW, Uhlig HH, Zilbauer M, Powrie F, Dougan G. Interleukin-22 promotes phagolysosomal fusion to induce protection against Salmonella enterica Typhimurium in human epithelial cells. Proc Natl Acad Sci U S A 2018;115:10118-23. [PMID: 30217896 DOI: 10.1073/pnas.1811866115] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
366 Petersen BS, Spehlmann ME, Raedler A, Stade B, Thomsen I, Rabionet R, Rosenstiel P, Schreiber S, Franke A. Whole genome and exome sequencing of monozygotic twins discordant for Crohn’s disease. BMC Genomics. 2014;15:564. [PMID: 24996980 DOI: 10.1186/1471-2164-15-564] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
367 Figliuolo da Paz VR, Jamwal DR, Kiela PR. Intestinal Regulatory T Cells. Adv Exp Med Biol 2021;1278:141-90. [PMID: 33523448 DOI: 10.1007/978-981-15-6407-9_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
368 Liu B, Tonkonogy SL, Sartor RB. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology. 2011;141:653-662, 662.e1-4. [PMID: 21679711 DOI: 10.1053/j.gastro.2011.04.053] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
369 Goodman RP, Chung DC. Clinical Genetic Testing in Gastroenterology. Clin Transl Gastroenterol 2016;7:e167. [PMID: 27124700 DOI: 10.1038/ctg.2016.23] [Reference Citation Analysis]
370 Giuffrida P, Cococcia S, Delliponti M, Lenti MV, Di Sabatino A. Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease. Cells 2019;8:E397. [PMID: 31052214 DOI: 10.3390/cells8050397] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
371 Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ramírez-Alejo N, Kilic SS, El Baghdadi J, Nonoyama S, Mahdaviani SA, Ailal F, Bousfiha A, Mansouri D, Nievas E, Ma CS, Rao G, Bernasconi A, Sun Kuehn H, Niemela J, Stoddard J, Deveau P, Cobat A, El Azbaoui S, Sabri A, Lim CK, Sundin M, Avery DT, Halwani R, Grant AV, Boisson B, Bogunovic D, Itan Y, Moncada-Velez M, Martinez-Barricarte R, Migaud M, Deswarte C, Alsina L, Kotlarz D, Klein C, Muller-Fleckenstein I, Fleckenstein B, Cormier-Daire V, Rose-John S, Picard C, Hammarstrom L, Puel A, Al-Muhsen S, Abel L, Chaussabel D, Rosenzweig SD, Minegishi Y, Tangye SG, Bustamante J, Casanova JL, Boisson-Dupuis S. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med 2015;212:1641-62. [PMID: 26304966 DOI: 10.1084/jem.20140280] [Cited by in Crossref: 184] [Cited by in F6Publishing: 162] [Article Influence: 26.3] [Reference Citation Analysis]
372 Shi N, Li N, Duan X, Niu H. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 2017;4:14. [PMID: 28465831 DOI: 10.1186/s40779-017-0122-9] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 20.4] [Reference Citation Analysis]
373 Nakano H, Kirino Y, Takeno M, Higashitani K, Nagai H, Yoshimi R, Yamaguchi Y, Kato I, Aoki I, Nakajima H. GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease. Arthritis Res Ther 2018;20:124. [PMID: 29895319 DOI: 10.1186/s13075-018-1613-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
374 Nunez N, Réot L, Menu E. Neonatal Immune System Ontogeny: The Role of Maternal Microbiota and Associated Factors. How Might the Non-Human Primate Model Enlighten the Path? Vaccines (Basel) 2021;9:584. [PMID: 34206053 DOI: 10.3390/vaccines9060584] [Reference Citation Analysis]
375 Hine AM, Loke P. Intestinal Macrophages in Resolving Inflammation. J Immunol 2019;203:593-9. [PMID: 31332080 DOI: 10.4049/jimmunol.1900345] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
376 Sutavani RV, Phair IR, Barker R, McFarlane A, Shpiro N, Lang S, Woodland A, Arthur JSC. Differential control of Toll-like receptor 4-induced interleukin-10 induction in macrophages and B cells reveals a role for p90 ribosomal S6 kinases. J Biol Chem 2018;293:2302-17. [PMID: 29229781 DOI: 10.1074/jbc.M117.805424] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
377 Denning TL, Bhatia AM, Kane AF, Patel RM, Denning PW. Pathogenesis of NEC: Role of the innate and adaptive immune response. Semin Perinatol 2017;41:15-28. [PMID: 27940091 DOI: 10.1053/j.semperi.2016.09.014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
378 Endale M, Aksoylar HI, Hoebe K. Central role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gut. Mediators Inflamm 2015;2015:436017. [PMID: 25944983 DOI: 10.1155/2015/436017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
379 Wu WH, Zegarra-Ruiz DF, Diehl GE. Intestinal Microbes in Autoimmune and Inflammatory Disease. Front Immunol 2020;11:597966. [PMID: 33424846 DOI: 10.3389/fimmu.2020.597966] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
380 Goldbach-Mansky R. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol 2012;167:391-404. [PMID: 22288582 DOI: 10.1111/j.1365-2249.2011.04533.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 77] [Article Influence: 10.1] [Reference Citation Analysis]
381 Plevy SE, Targan SR. Future therapeutic approaches for inflammatory bowel diseases. Gastroenterology. 2011;140:1838-1846. [PMID: 21530750 DOI: 10.1053/j.gastro.2011.02.014] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
382 Girardelli M, Arrigo S, Barabino A, Loganes C, Morreale G, Crovella S, Tommasini A, Bianco AM. The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency. BMC Pediatr 2015;15:208. [PMID: 26671016 DOI: 10.1186/s12887-015-0522-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
383 Conrad MA, Kelsen JR. Genomic and Immunologic Drivers of Very Early-Onset Inflammatory Bowel Disease. Pediatr Dev Pathol 2019;22:183-93. [PMID: 30841788 DOI: 10.1177/1093526619834807] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
384 Lee WS, Ng RT, Chan KW, Lau YL. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort. World J Gastroenterol 2016; 22(48): 10653-10662 [PMID: 28082818 DOI: 10.3748/wjg.v22.i48.10653] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
385 Nambu R, Muise AM. Advanced Understanding of Monogenic Inflammatory Bowel Disease. Front Pediatr 2020;8:618918. [PMID: 33553075 DOI: 10.3389/fped.2020.618918] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
386 Pedros C, Duguet F, Saoudi A, Chabod M. Disrupted regulatory T cell homeostasis in inflammatory bowel diseases. World J Gastroenterol 2016; 22(3): 974-995 [PMID: 26811641 DOI: 10.3748/wjg.v22.i3.974] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
387 Wilkins BJ, Kelsen JR, Conrad MA. A Pattern-based Pathology Approach to Very Early-onset Inflammatory Bowel Disease: Thinking Beyond Crohn Disease and Ulcerative Colitis. Adv Anat Pathol 2022;29:62-70. [PMID: 34813528 DOI: 10.1097/PAP.0000000000000327] [Reference Citation Analysis]
388 Gu QP, Xie JF, Chen J, Zhang Y, Hong K, Bai AP. Treatment of murine colitis with IL-10-secreting Escherichia coliShijie Huaren Xiaohua Zazhi 2011; 19(27): 2835-2840 [DOI: 10.11569/wcjd.v19.i27.2835] [Reference Citation Analysis]
389 Sharpton T, Lyalina S, Luong J, Pham J, Deal EM, Armour C, Gaulke C, Sanjabi S, Pollard KS. Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice. mSystems 2017;2:e00036-17. [PMID: 28904997 DOI: 10.1128/mSystems.00036-17] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
390 Oikonomou V, Break TJ, Gaffen SL, Moutsopoulos NM, Lionakis MS. Infections in the monogenic autoimmune syndrome APECED. Curr Opin Immunol 2021;72:286-97. [PMID: 34418591 DOI: 10.1016/j.coi.2021.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
391 Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis. 2010;16:1583-1597. [PMID: 20803699 DOI: 10.1002/ibd.21282] [Cited by in Crossref: 222] [Cited by in F6Publishing: 211] [Article Influence: 18.5] [Reference Citation Analysis]
392 Galatola M, Miele E, Strisciuglio C, Paparo L, Rega D, Delrio P, Duraturo F, Martinelli M, Rossi GB, Staiano A, Izzo P, Rosa MD. Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. World J Gastroenterol 2013; 19(46): 8659-8670 [PMID: 24379584 DOI: 10.3748/wjg.v19.i46.8659] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
393 Lim HK, Huang SXL, Chen J, Kerner G, Gilliaux O, Bastard P, Dobbs K, Hernandez N, Goudin N, Hasek ML, García Reino EJ, Lafaille FG, Lorenzo L, Luthra P, Kochetkov T, Bigio B, Boucherit S, Rozenberg F, Vedrinne C, Keller MD, Itan Y, García-Sastre A, Celard M, Orange JS, Ciancanelli MJ, Meyts I, Zhang Q, Abel L, Notarangelo LD, Snoeck HW, Casanova JL, Zhang SY. Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med 2019;216:2038-56. [PMID: 31217193 DOI: 10.1084/jem.20181621] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 18.3] [Reference Citation Analysis]
394 Nagaishi K, Arimura Y, Fujimiya M. Stem cell therapy for inflammatory bowel disease. J Gastroenterol. 2015;50:280-286. [PMID: 25618180 DOI: 10.1007/s00535-015-1040-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
395 Brockmann L, Gagliani N, Steglich B, Giannou AD, Kempski J, Pelczar P, Geffken M, Mfarrej B, Huber F, Herkel J, Wan YY, Esplugues E, Battaglia M, Krebs CF, Flavell RA, Huber S. IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo. J Immunol 2017;198:1130-41. [PMID: 28003377 DOI: 10.4049/jimmunol.1601045] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 8.7] [Reference Citation Analysis]
396 Fang D, Zhu J. Molecular switches for regulating the differentiation of inflammatory and IL-10-producing anti-inflammatory T-helper cells. Cell Mol Life Sci 2020;77:289-303. [PMID: 31432236 DOI: 10.1007/s00018-019-03277-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
397 Hale LP, Greer PK. A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features. PLoS One. 2012;7:e41797. [PMID: 22848611 DOI: 10.1371/journal.pone.0041797] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
398 Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev 2021;:103017. [PMID: 34902606 DOI: 10.1016/j.autrev.2021.103017] [Reference Citation Analysis]
399 Shim JO. Recent Advance in Very Early Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2019;22:41-9. [PMID: 30671372 DOI: 10.5223/pghn.2019.22.1.41] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
400 de Jesus AA, Goldbach-Mansky R. Genetically defined autoinflammatory diseases. Oral Dis 2016;22:591-604. [PMID: 26837051 DOI: 10.1111/odi.12448] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
401 Murray PJ, Smale ST. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat Immunol 2012;13:916-24. [PMID: 22990889 DOI: 10.1038/ni.2391] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 11.5] [Reference Citation Analysis]
402 Parkes M. Personalised medicine and genetic prediction--are we there yet? Clin Med (Lond) 2013;13 Suppl 6:s62-4. [PMID: 24298187 DOI: 10.7861/clinmedicine.13-6-s62] [Reference Citation Analysis]
403 Hang L, Blum AM, Setiawan T, Urban JP Jr, Stoyanoff KM, Weinstock JV. Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis. J Immunol 2013;191:1927-34. [PMID: 23851695 DOI: 10.4049/jimmunol.1201457] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 6.2] [Reference Citation Analysis]
404 Sun M, He C, Chen L, Yang W, Wu W, Chen F, Cao AT, Yao S, Dann SM, Dhar TGM, Salter-Cid L, Zhao Q, Liu Z, Cong Y. RORγt Represses IL-10 Production in Th17 Cells To Maintain Their Pathogenicity in Inducing Intestinal Inflammation. J Immunol 2019;202:79-92. [PMID: 30478092 DOI: 10.4049/jimmunol.1701697] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
405 Ning K, Gettler K, Zhang W, Ng SM, Bowen BM, Hyams J, Stephens MC, Kugathasan S, Denson LA, Schadt EE, Hoffman GE, Cho JH. Improved integrative framework combining association data with gene expression features to prioritize Crohn's disease genes. Hum Mol Genet 2015;24:4147-57. [PMID: 25935003 DOI: 10.1093/hmg/ddv142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
406 Nameirakpam J, Rikhi R, Rawat SS, Sharma J, Suri D. Genetics on early onset inflammatory bowel disease: An update. Genes Dis 2020;7:93-106. [PMID: 32181280 DOI: 10.1016/j.gendis.2019.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
407 Aktas B, De Wolfe TJ, Safdar N, Darien BJ, Steele JL. The Impact of Lactobacillus casei on the Composition of the Cecal Microbiota and Innate Immune System Is Strain Specific. PLoS One 2016;11:e0156374. [PMID: 27244133 DOI: 10.1371/journal.pone.0156374] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
408 Li Z, Peres AG, Damian AC, Madrenas J. Immunomodulation and Disease Tolerance to Staphylococcus aureus. Pathogens 2015;4:793-815. [PMID: 26580658 DOI: 10.3390/pathogens4040793] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
409 de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 2015;33:823-74. [PMID: 25706096 DOI: 10.1146/annurev-immunol-032414-112227] [Cited by in Crossref: 173] [Cited by in F6Publishing: 137] [Article Influence: 24.7] [Reference Citation Analysis]
410 Kobayashi T, Matsuoka K, Sheikh SZ, Elloumi HZ, Kamada N, Hisamatsu T, Hansen JJ, Doty KR, Pope SD, Smale ST. NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunity. J Immunol. 2011;186:4649-4655. [PMID: 21383239 DOI: 10.4049/jimmunol.1003888] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 6.0] [Reference Citation Analysis]
411 Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature 2020;578:527-39. [PMID: 32103191 DOI: 10.1038/s41586-020-2025-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 39.0] [Reference Citation Analysis]
412 Notarangelo LD, Bacchetta R, Casanova JL, Su HC. Human inborn errors of immunity: An expanding universe. Sci Immunol 2020;5:eabb1662. [PMID: 32651211 DOI: 10.1126/sciimmunol.abb1662] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
413 Suuring M, Moreau A. Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies. Int J Mol Sci 2021;22:7970. [PMID: 34360736 DOI: 10.3390/ijms22157970] [Reference Citation Analysis]
414 Marcuzzi A, Bianco AM, Girardelli M, Tommasini A, Martelossi S, Monasta L, Crovella S. Genetic and functional profiling of Crohn's disease: autophagy mechanism and susceptibility to infectious diseases. Biomed Res Int 2013;2013:297501. [PMID: 23738324 DOI: 10.1155/2013/297501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
415 Amend A, Wickli N, Schäfer AL, Sprenger DTL, Manz RA, Voll RE, Chevalier N. Dual Role of Interleukin-10 in Murine NZB/W F1 Lupus. Int J Mol Sci 2021;22:1347. [PMID: 33572870 DOI: 10.3390/ijms22031347] [Reference Citation Analysis]
416 Frydrych LM, Fattahi F, He K, Ward PA, Delano MJ. Diabetes and Sepsis: Risk, Recurrence, and Ruination. Front Endocrinol (Lausanne) 2017;8:271. [PMID: 29163354 DOI: 10.3389/fendo.2017.00271] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
417 Jergens AE, Parvinroo S, Kopper J, Wannemuehler MJ. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:669913. [PMID: 34513862 DOI: 10.3389/fmed.2021.669913] [Reference Citation Analysis]
418 Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol. 2013;4:280. [PMID: 24062746 DOI: 10.3389/fimmu.2013.00280] [Cited by in Crossref: 245] [Cited by in F6Publishing: 237] [Article Influence: 27.2] [Reference Citation Analysis]
419 Metzger RN, Krug AB, Eisenächer K. Enteric Virome Sensing-Its Role in Intestinal Homeostasis and Immunity. Viruses 2018;10:E146. [PMID: 29570694 DOI: 10.3390/v10040146] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
420 Colman RJ, Dhaliwal J, Rosen MJ. Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine. Front Pediatr 2021;9:634739. [PMID: 33681110 DOI: 10.3389/fped.2021.634739] [Reference Citation Analysis]
421 Ray A, Basu S, Gharaibeh RZ, Cook LC, Kumar R, Lefkowitz EJ, Walker CR, Morrow CD, Franklin CL, Geiger TL, Salzman NH, Fodor A, Dittel BN. Gut Microbial Dysbiosis Due to Helicobacter Drives an Increase in Marginal Zone B Cells in the Absence of IL-10 Signaling in Macrophages. J Immunol 2015;195:3071-85. [PMID: 26324769 DOI: 10.4049/jimmunol.1500153] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
422 Mishima Y, Oka A, Liu B, Herzog JW, Eun CS, Fan TJ, Bulik-Sullivan E, Carroll IM, Hansen JJ, Chen L, Wilson JE, Fisher NC, Ting JP, Nochi T, Wahl A, Garcia JV, Karp CL, Sartor RB. Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells. J Clin Invest 2019;129:3702-16. [PMID: 31211700 DOI: 10.1172/JCI93820] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 16.7] [Reference Citation Analysis]
423 Veenbergen S, Li P, Raatgeep HC, Lindenbergh-Kortleve DJ, Simons-Oosterhuis Y, Farrel A, Costes LMM, Joosse ME, van Berkel LA, de Ruiter LF, van Leeuwen MA, Winter D, Holland SM, Freeman AF, Wakabayashi Y, Zhu J, de Ridder L, Driessen GJ, Escher JC, Leonard WJ, Samsom JN. IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4+ T cells: relevance to inflammatory bowel disease. Mucosal Immunol 2019;12:1201-11. [PMID: 31417161 DOI: 10.1038/s41385-019-0194-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
424 Redhu NS, Bakthavatchalu V, Conaway EA, Shouval DS, Tsou A, Goettel JA, Biswas A, Wang C, Field M, Muller W, Bleich A, Li N, Gerber GK, Bry L, Fox JG, Snapper SB, Horwitz BH. Macrophage dysfunction initiates colitis during weaning of infant mice lacking the interleukin-10 receptor. Elife 2017;6:e27652. [PMID: 28678006 DOI: 10.7554/eLife.27652] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
425 Zhao M, Burisch J. Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease. Dig Dis Sci 2019;64:1759-69. [PMID: 31073736 DOI: 10.1007/s10620-019-05648-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
426 Pattison MJ, Naik RJ, Reyskens KMSE, Arthur JSC. Loss of Mef2D function enhances TLR induced IL-10 production in macrophages. Biosci Rep 2020;40:BSR20201859. [PMID: 32725155 DOI: 10.1042/BSR20201859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Fodil N, Langlais D, Gros P. Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection. Trends Immunol 2016;37:126-40. [PMID: 26791050 DOI: 10.1016/j.it.2015.12.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
428 Zheng HB, de la Morena MT, Suskind DL. The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease. Front Immunol 2021;12:675186. [PMID: 34122435 DOI: 10.3389/fimmu.2021.675186] [Reference Citation Analysis]
429 Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence 2022;13:89-121. [PMID: 34964702 DOI: 10.1080/21505594.2021.2019950] [Reference Citation Analysis]
430 Moon JS. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intest Res 2019;17:17-23. [PMID: 30625263 DOI: 10.5217/ir.2018.00139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
431 Gordon H, Trier Moller F, Andersen V, Harbord M. Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies. Inflamm Bowel Dis. 2015;21:1428-1434. [PMID: 25895112 DOI: 10.1097/mib.0000000000000393] [Cited by in Crossref: 13] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
432 Kaunitz J, Nayyar P. Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease? F1000Res. 2015;4. [PMID: 27508055 DOI: 10.12688/f1000research.6456.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
433 Troncone E, Marafini I, Stolfi C, Monteleone G. Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer. Front Immunol 2018;9:1407. [PMID: 29973939 DOI: 10.3389/fimmu.2018.01407] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
434 Hsu P, Nanan RK. Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol 2014;5:125. [PMID: 24734032 DOI: 10.3389/fimmu.2014.00125] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 8.3] [Reference Citation Analysis]
435 Thiagarajah JR, Kamin DS, Acra S, Goldsmith JD, Roland JT, Lencer WI, Muise AM, Goldenring JR, Avitzur Y, Martín MG; PediCODE Consortium. Advances in Evaluation of Chronic Diarrhea in Infants. Gastroenterology 2018;154:2045-2059.e6. [PMID: 29654747 DOI: 10.1053/j.gastro.2018.03.067] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 15.8] [Reference Citation Analysis]
436 Freij BJ, Hanrath AT, Chen R, Hambleton S, Duncan CJA. Life-Threatening Influenza, Hemophagocytic Lymphohistiocytosis and Probable Vaccine-Strain Varicella in a Novel Case of Homozygous STAT2 Deficiency. Front Immunol 2020;11:624415. [PMID: 33679716 DOI: 10.3389/fimmu.2020.624415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
437 Barry JC, Shakibakho S, Durrer C, Simtchouk S, Jawanda KK, Cheung ST, Mui AL, Little JP. Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes. Sci Rep 2016;6:21244. [PMID: 26883847 DOI: 10.1038/srep21244] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
438 Bonelli M, Shih HY, Hirahara K, Singelton K, Laurence A, Poholek A, Hand T, Mikami Y, Vahedi G, Kanno Y, O'Shea JJ. Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes. Curr Top Microbiol Immunol 2014;381:279-326. [PMID: 24831346 DOI: 10.1007/82_2014_371] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
439 Kelaidi C, Tzotzola V, Polychronopoulou S. The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay. Fam Cancer 2021. [PMID: 34128135 DOI: 10.1007/s10689-021-00266-w] [Reference Citation Analysis]
440 Sheridan J, Mack DR, Amre DK, Israel DM, Cherkasov A, Li H, Grimard G, Steiner TS. A non-synonymous coding variant (L616F) in the TLR5 gene is potentially associated with Crohn's disease and influences responses to bacterial flagellin. PLoS One 2013;8:e61326. [PMID: 23593463 DOI: 10.1371/journal.pone.0061326] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
441 van Haaften-Visser DY, Harakalova M, Mocholi E, van Montfrans JM, Elkadri A, Rieter E, Fiedler K, van Hasselt PM, Triffaux EMM, van Haelst MM, Nijman IJ, Kloosterman WP, Nieuwenhuis EES, Muise AM, Cuppen E, Houwen RHJ, Coffer PJ. Ankyrin repeat and zinc-finger domain-containing 1 mutations are associated with infantile-onset inflammatory bowel disease. J Biol Chem 2017;292:7904-20. [PMID: 28302725 DOI: 10.1074/jbc.M116.772038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
442 Baydi Z, Limami Y, Khalki L, Zaid N, Naya A, Mtairag EM, Oudghiri M, Zaid Y. An Update of Research Animal Models of Inflammatory Bowel Disease. ScientificWorldJournal 2021;2021:7479540. [PMID: 34938152 DOI: 10.1155/2021/7479540] [Reference Citation Analysis]
443 Nagy E, Rodriguiz RM, Wetsel WC, MacIver NJ, Hale LP. Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel Disease. PLoS One 2016;11:e0152764. [PMID: 27045690 DOI: 10.1371/journal.pone.0152764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
444 Swafford D, Shanmugam A, Ranganathan P, Manoharan I, Hussein MS, Patel N, Sifuentes H, Koni PA, Prasad PD, Thangaraju M, Manicassamy S. The Wnt-β-Catenin-IL-10 Signaling Axis in Intestinal APCs Protects Mice from Colitis-Associated Colon Cancer in Response to Gut Microbiota. J Immunol 2020;205:2265-75. [PMID: 32917787 DOI: 10.4049/jimmunol.1901376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
445 Mudd TW Jr, Lu C, Klement JD, Liu K. MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironment. Cell Immunol 2021;360:104260. [PMID: 33352466 DOI: 10.1016/j.cellimm.2020.104260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
446 Lundy SK, Lukacs NW. Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression. Front Immunol 2013;4:39. [PMID: 23429492 DOI: 10.3389/fimmu.2013.00039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
447 Hombach AA, Rappl G, Abken H. Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30- Tumors. Mol Ther 2019;27:1825-35. [PMID: 31331813 DOI: 10.1016/j.ymthe.2019.06.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
448 Yu Y, Chen Y, Wang FL, Sun J, Li HJ, Liu JM. Cytokines Interleukin 4 (IL-4) and Interleukin 10 (IL-10) Gene Polymorphisms as Potential Host Susceptibility Factors in Virus-Induced Encephalitis. Med Sci Monit 2017;23:4541-8. [PMID: 28935853 DOI: 10.12659/msm.904364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
449 Sakurai D, Zhao J, Deng Y, Kelly JA, Brown EE, Harley JB, Bae SC, Alarcόn-Riquelme ME, Edberg JC, Kimberly RP, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, Alarcón GS, Kaufman KM, Vyse TJ, Jacob CO, Gaffney PM, Sivils KM, James JA, Kamen DL, Gilkeson GS, Niewold TB, Merrill JT, Scofield RH, Criswell LA, Stevens AM, Boackle SA, Kim JH, Choi J, Pons-Estel BA, Freedman BI, Anaya JM, Martin J, Yu CY, Chang DM, Song YW, Langefeld CD, Chen W, Grossman JM, Cantor RM, Hahn BH, Tsao BP; BIOLUPUS and GENLES networks., Argentine Collaborative Group. Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. PLoS Genet 2013;9:e1003870. [PMID: 24130510 DOI: 10.1371/journal.pgen.1003870] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
450 Guan D, Wang Z, Huo J, Xu S, Lam KP. Bruton's tyrosine kinase regulates gut immune homeostasis through attenuating Th1 response. Cell Death Dis 2021;12:431. [PMID: 33931590 DOI: 10.1038/s41419-021-03702-y] [Reference Citation Analysis]
451 Cifaldi C, Chiriaco M, Di Matteo G, Di Cesare S, Alessia S, De Angelis P, Rea F, Angelino G, Pastore M, Ferradini V, Pagliara D, Cancrini C, Rossi P, Bertaina A, Finocchi A. Novel X-Linked Inhibitor of Apoptosis Mutation in Very Early-Onset Inflammatory Bowel Disease Child Successfully Treated with HLA-Haploidentical Hemapoietic Stem Cells Transplant after Removal of αβ+ T and B Cells. Front Immunol 2017;8:1893. [PMID: 29312354 DOI: 10.3389/fimmu.2017.01893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
452 Conrad MA, Carreon CK, Dawany N, Russo P, Kelsen JR. Distinct Histopathological Features at Diagnosis of Very Early Onset Inflammatory Bowel Disease. J Crohns Colitis 2019;13:615-25. [PMID: 30551128 DOI: 10.1093/ecco-jcc/jjy212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
453 Diefenhardt P, Nosko A, Kluger MA, Richter JV, Wegscheid C, Kobayashi Y, Tiegs G, Huber S, Flavell RA, Stahl RAK, Steinmetz OM. IL-10 Receptor Signaling Empowers Regulatory T Cells to Control Th17 Responses and Protect from GN. J Am Soc Nephrol 2018;29:1825-37. [PMID: 29866800 DOI: 10.1681/ASN.2017091044] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
454 Xu S, Zou H, Zhang H, Zhu S, Zhou R, Li J. Investigation of inflammatory bowel disease risk factors in 4 families in central China. Exp Ther Med. 2018;15:1367-1375. [PMID: 29399122 DOI: 10.3892/etm.2017.5582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
455 Takahashi R, Noguchi T, Mizoguchi Y, Shimoyama T, Nakazawa T, Ikuta T. A Synbiotic with Tumor Necrosis Factor-α Inhibitory Activity Ameliorates Experimental Jejunoileal Mucosal Injury. Biomed Res Int 2018;2018:9184093. [PMID: 29862296 DOI: 10.1155/2018/9184093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
456 Lv H, Qiao B, Fang L, Yang L, Wang Q, Wu S, Ren P, Li L. Neonatal Crohn's disease with Oral ulcer as the first symptom caused by a compound heterozygote mutation in IL-10RA: a case report. Hereditas 2019;156:38. [PMID: 31889944 DOI: 10.1186/s41065-019-0114-8] [Reference Citation Analysis]
457 Hartono S, Ippoliti MR, Mastroianni M, Torres R, Rider NL. Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases. Clin Rev Allergy Immunol 2019;57:145-65. [PMID: 29754192 DOI: 10.1007/s12016-018-8689-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
458 Landwehr-Kenzel S, Henneke P. Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and Disease. Front Immunol 2014;5:519. [PMID: 25400631 DOI: 10.3389/fimmu.2014.00519] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
459 Milner JD, Sandler NG, Douek DC. Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections. Curr Opin HIV AIDS 2010;5:179-83. [PMID: 20543597 DOI: 10.1097/COH.0b013e328335ed3e] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
460 Moran CJ, Walters TD, Guo CH, Kugathasan S, Klein C, Turner D, Wolters VM, Bandsma RH, Mouzaki M, Zachos M. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis. 2013;19:115-123. [PMID: 22550014 DOI: 10.1002/ibd.22974] [Cited by in Crossref: 173] [Cited by in F6Publishing: 154] [Article Influence: 19.2] [Reference Citation Analysis]
461 Bamidele AO, Svingen PA, Sagstetter MR, Sarmento OF, Gonzalez M, Braga Neto MB, Kugathasan S, Lomberk G, Urrutia RA, Faubion WA Jr. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation. Cell Mol Gastroenterol Hepatol 2019;7:55-71. [PMID: 30510991 DOI: 10.1016/j.jcmgh.2018.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
462 Amre DK, Mack DR, Morgan K, Israel D, Deslandres C, Seidman EG, Lambrette P, Costea I, Krupoves A, Fegury H. Association between genome-wide association studies reported SNPs and pediatric-onset Crohn’s disease in Canadian children. Hum Genet. 2010;128:131-135. [PMID: 20473688 DOI: 10.1007/s00439-010-0835-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
463 Schreiber S, Rosenstiel P, Franke A. [Genetic etiology of chronic inflammatory bowel disease]. Internist (Berl) 2014;55:156-64. [PMID: 24518921 DOI: 10.1007/s00108-013-3303-y] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
464 Kelsen JR, Russo P, Sullivan KE. Early-Onset Inflammatory Bowel Disease. Immunol Allergy Clin North Am 2019;39:63-79. [PMID: 30466773 DOI: 10.1016/j.iac.2018.08.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
465 Troncone E, Marafini I, Stolfi C, Monteleone G. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer. Int J Mol Sci 2021;22:3922. [PMID: 33920230 DOI: 10.3390/ijms22083922] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
466 Grigg JB, Sonnenberg GF. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases. J Immunol 2017;198:564-71. [PMID: 28069751 DOI: 10.4049/jimmunol.1601621] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
467 Kiesler P, Fuss IJ, Strober W. Experimental Models of Inflammatory Bowel Diseases. Cell Mol Gastroenterol Hepatol 2015;1:154-70. [PMID: 26000334 DOI: 10.1016/j.jcmgh.2015.01.006] [Cited by in Crossref: 287] [Cited by in F6Publishing: 270] [Article Influence: 41.0] [Reference Citation Analysis]
468 Kabat AM, Pott J, Maloy KJ. The Mucosal Immune System and Its Regulation by Autophagy. Front Immunol 2016;7:240. [PMID: 27446072 DOI: 10.3389/fimmu.2016.00240] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
469 Lin Z, Wang Z, Hegarty JP, Lin TR, Wang Y, Deiling S, Wu R, Thomas NJ, Floros J. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease. World J Gastroenterol 2017; 23(27): 4897-4909 [PMID: 28785144 DOI: 10.3748/wjg.v23.i27.4897] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
470 Crowley E, Warner N, Pan J, Khalouei S, Elkadri A, Fiedler K, Foong J, Turinsky AL, Bronte-Tinkew D, Zhang S, Hu J, Tian D, Li D, Horowitz J, Siddiqui I, Upton J, Roifman CM, Church PC, Wall DA, Ramani AK, Kotlarz D, Klein C, Uhlig H, Snapper SB, Gonzaga-Jauregui C, Paterson AD, McGovern DPB, Brudno M, Walters TD, Griffiths AM, Muise AM. Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center. Gastroenterology 2020;158:2208-20. [PMID: 32084423 DOI: 10.1053/j.gastro.2020.02.023] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
471 Ozen A, Comrie WA, Ardy RC, Domínguez Conde C, Dalgic B, Beser ÖF, Morawski AR, Karakoc-Aydiner E, Tutar E, Baris S, Ozcay F, Serwas NK, Zhang Y, Matthews HF, Pittaluga S, Folio LR, Unlusoy Aksu A, McElwee JJ, Krolo A, Kiykim A, Baris Z, Gulsan M, Ogulur I, Snapper SB, Houwen RHJ, Leavis HL, Ertem D, Kain R, Sari S, Erkan T, Su HC, Boztug K, Lenardo MJ. CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. N Engl J Med 2017;377:52-61. [PMID: 28657829 DOI: 10.1056/NEJMoa1615887] [Cited by in Crossref: 74] [Cited by in F6Publishing: 35] [Article Influence: 14.8] [Reference Citation Analysis]
472 Smith AM, Sewell GW, Levine AP, Chew TS, Dunne J, O'Shea NR, Smith PJ, Harrison PJ, Macdonald CM, Bloom SL, Segal AW. Disruption of macrophage pro-inflammatory cytokine release in Crohn's disease is associated with reduced optineurin expression in a subset of patients. Immunology 2015;144:45-55. [PMID: 24943399 DOI: 10.1111/imm.12338] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
473 Boisson-Dupuis S, Kong XF, Okada S, Cypowyj S, Puel A, Abel L, Casanova JL. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol 2012;24:364-78. [PMID: 22651901 DOI: 10.1016/j.coi.2012.04.011] [Cited by in Crossref: 188] [Cited by in F6Publishing: 172] [Article Influence: 18.8] [Reference Citation Analysis]
474 Ensari A, Kelsen J, Russo P. Newcomers in paediatric GI pathology: childhood enteropathies including very early onset monogenic IBD. Virchows Arch 2018;472:111-23. [PMID: 28718031 DOI: 10.1007/s00428-017-2197-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
475 Hug H, Mohajeri MH, La Fata G. Toll-Like Receptors: Regulators of the Immune Response in the Human Gut. Nutrients. 2018;10. [PMID: 29438282 DOI: 10.3390/nu10020203] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 18.0] [Reference Citation Analysis]
476 Smith AM, Qualls JE, O'Brien K, Balouzian L, Johnson PF, Schultz-Cherry S, Smale ST, Murray PJ. A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3. J Biol Chem 2011;286:23582-90. [PMID: 21566115 DOI: 10.1074/jbc.M111.249235] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
477 Xue A, Qian X, Gao X, Wang P, Wang L, Zheng C, Huang Z, Hu W, Shi J, Huang Y. Fecal Microbial Signatures Are Associated With Engraftment Failure Following Umbilical Cord Blood Transplantation in Pediatric Crohn's Disease Patients With IL10RA Deficiency. Front Pharmacol 2020;11:580817. [PMID: 33162889 DOI: 10.3389/fphar.2020.580817] [Reference Citation Analysis]
478 Kobayashi T, Matsuoka K, Sheikh SZ, Russo SM, Mishima Y, Collins C, deZoeten EF, Karp CL, Ting JP, Sartor RB, Plevy SE. IL-10 regulates Il12b expression via histone deacetylation: implications for intestinal macrophage homeostasis. J Immunol 2012;189:1792-9. [PMID: 22786766 DOI: 10.4049/jimmunol.1200042] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
479 Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell 2010;140:784-90. [PMID: 20303869 DOI: 10.1016/j.cell.2010.03.002] [Cited by in Crossref: 317] [Cited by in F6Publishing: 254] [Article Influence: 26.4] [Reference Citation Analysis]
480 An J, Nagaishi T, Watabe T, Naruse TK, Watanabe M, Kimura A. MKL1 expressed in macrophages contributes to the development of murine colitis. Sci Rep 2017;7:13650. [PMID: 29057966 DOI: 10.1038/s41598-017-13629-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
481 Petersen BS, Fredrich B, Hoeppner MP, Ellinghaus D, Franke A. Opportunities and challenges of whole-genome and -exome sequencing. BMC Genet 2017;18:14. [PMID: 28193154 DOI: 10.1186/s12863-017-0479-5] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 16.8] [Reference Citation Analysis]
482 Miyoshi J, Chang EB. The gut microbiota and inflammatory bowel diseases. Transl Res 2017;179:38-48. [PMID: 27371886 DOI: 10.1016/j.trsl.2016.06.002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 11.7] [Reference Citation Analysis]
483 Canani RB, Castaldo G, Bacchetta R, Martín MG, Goulet O. Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies. Nat Rev Gastroenterol Hepatol 2015;12:293-302. [PMID: 25782092 DOI: 10.1038/nrgastro.2015.44] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
484 Al-toma A, Nijeboer P, Bouma G, Visser O, Mulder CJ. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol 2014; 20(46): 17368-17375 [PMID: 25516648 DOI: 10.3748/wjg.v20.i46.17368] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
485 Kelsen JR, Dawany N, Moran CJ, Petersen BS, Sarmady M, Sasson A, Pauly-Hubbard H, Martinez A, Maurer K, Soong J, Rappaport E, Franke A, Keller A, Winter HS, Mamula P, Piccoli D, Artis D, Sonnenberg GF, Daly M, Sullivan KE, Baldassano RN, Devoto M. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology 2015;149:1415-24. [PMID: 26193622 DOI: 10.1053/j.gastro.2015.07.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 7.9] [Reference Citation Analysis]
486 Kim SJ, Howe C, Mitchell J, Choo J, Powers A, Oikonomopoulos A, Pothoulakis C, Hommes DW, Im E, Rhee SH. Autotaxin loss accelerates intestinal inflammation by suppressing TLR4-mediated immune responses. EMBO Rep 2020;21:e49332. [PMID: 32875703 DOI: 10.15252/embr.201949332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
487 He H, Ghosh S, Yang H. Nanomedicines for dysfunctional macrophage-associated diseases. J Control Release 2017;247:106-26. [PMID: 28057522 DOI: 10.1016/j.jconrel.2016.12.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
488 Boyapati R, Satsangi J, Ho GT. Pathogenesis of Crohn's disease. F1000Prime Rep. 2015;7:44. [PMID: 26097717 DOI: 10.12703/p7-44] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
489 Sanchez GA, de Jesus AA, Goldbach-Mansky R. Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation. Rheum Dis Clin North Am 2013;39:701-34. [PMID: 24182851 DOI: 10.1016/j.rdc.2013.08.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
490 Murugan D, Albert MH, Langemeier J, Bohne J, Puchalka J, Järvinen PM, Hauck F, Klenk AK, Prell C, Schatz S, Diestelhorst J, Sciskala B, Kohistani N, Belohradsky BH, Müller S, Kirchner T, Walter MR, Bufler P, Muise AM, Snapper SB, Koletzko S, Klein C, Kotlarz D. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol 2014;34:331-9. [PMID: 24519095 DOI: 10.1007/s10875-014-9992-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
491 Carey AJ, Tan CK, Ulett GC. Infection-induced IL-10 and JAK-STAT: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes. JAKSTAT 2012;1:159-67. [PMID: 24058765 DOI: 10.4161/jkst.19918] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
492 Gurung P, Li B, Subbarao Malireddi RK, Lamkanfi M, Geiger TL, Kanneganti TD. Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation. Sci Rep. 2015;5:14488. [PMID: 26412089 DOI: 10.1038/srep14488] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 11.6] [Reference Citation Analysis]
493 Bakdash G, Vogelpoel LT, van Capel TM, Kapsenberg ML, de Jong EC. Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells. Mucosal Immunol. 2015;8:265-278. [PMID: 25027601 DOI: 10.1038/mi.2014.64] [Cited by in Crossref: 131] [Cited by in F6Publishing: 128] [Article Influence: 16.4] [Reference Citation Analysis]
494 Chen JS, Hu F, Kugathasan S, Jorde LB, Nix D, Rutherford A, Denson L, Watkins WS, Prahalad S, Huff C, Guthery SL. Targeted Gene Sequencing in Children with Crohn's Disease and Their Parents: Implications for Missing Heritability. G3 (Bethesda) 2018;8:2881-8. [PMID: 30166421 DOI: 10.1534/g3.118.200404] [Reference Citation Analysis]
495 Park SC, Jeen YT. Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients. Cells 2019;8:E404. [PMID: 31052430 DOI: 10.3390/cells8050404] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
496 Lien R, Lin YF, Lai MW, Weng HY, Wu RC, Jaing TH, Huang JL, Tsai SF, Lee WI. Novel Mutations of the Tetratricopeptide Repeat Domain 7A Gene and Phenotype/Genotype Comparison. Front Immunol 2017;8:1066. [PMID: 28936210 DOI: 10.3389/fimmu.2017.01066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
497 Bolton C, Burch N, Morgan J, Harrison B, Pandey S, Pagnamenta AT;  Oxford IBD cohort investigators ; Taylor JC, Taylor JM, Marsh JCW, Potter V, Travis S, Uhlig HH. Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell Transplantation. J Crohns Colitis. 2020;14:142-147. [PMID: 31157858 DOI: 10.1093/ecco-jcc/jjz112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
498 Tanoue T, Atarashi K, Honda K. Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol. 2016;16:295-309. [PMID: 27087661 DOI: 10.1038/nri.2016.36] [Cited by in Crossref: 264] [Cited by in F6Publishing: 243] [Article Influence: 44.0] [Reference Citation Analysis]
499 Bianco AM, Girardelli M, Tommasini A. Genetics of inflammatory bowel disease from multifactorial to monogenic forms. World J Gastroenterol 2015; 21(43): 12296-12310 [PMID: 26604638 DOI: 10.3748/wjg.v21.i43.12296] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
500 Amodio G, Gregori S. Dendritic cells a double-edge sword in autoimmune responses. Front Immunol 2012;3:233. [PMID: 22876246 DOI: 10.3389/fimmu.2012.00233] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
501 Dong F, Xiao F, Ge T, Li X, Xu W, Wu S, Zhang T, Wang Y. Case Report: A Novel Compound Heterozygous Mutation in IL-10RA in a Chinese Child With Very Early-Onset Inflammatory Bowel Disease. Front Pediatr 2021;9:678390. [PMID: 34113591 DOI: 10.3389/fped.2021.678390] [Reference Citation Analysis]
502 Gettler K, Giri M, Kenigsberg E, Martin J, Chuang LS, Hsu NY, Denson LA, Hyams JS, Griffiths A, Noe JD, Crandall WV, Mack DR, Kellermayer R, Abraham C, Hoffman G, Kugathasan S, Cho JH. Prioritizing Crohn's disease genes by integrating association signals with gene expression implicates monocyte subsets. Genes Immun 2019;20:577-88. [PMID: 30692607 DOI: 10.1038/s41435-019-0059-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
503 Banchereau J, Pascual V, O'Garra A. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 2012;13:925-31. [PMID: 22990890 DOI: 10.1038/ni.2406] [Cited by in Crossref: 257] [Cited by in F6Publishing: 243] [Article Influence: 25.7] [Reference Citation Analysis]
504 Volk T, Pannicke U, Reisli I, Bulashevska A, Ritter J, Björkman A, Schäffer AA, Fliegauf M, Sayar EH, Salzer U, Fisch P, Pfeifer D, Di Virgilio M, Cao H, Yang F, Zimmermann K, Keles S, Caliskaner Z, Güner SÜ, Schindler D, Hammarström L, Rizzi M, Hummel M, Pan-Hammarström Q, Schwarz K, Grimbacher B. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency. Hum Mol Genet 2015;24:7361-72. [PMID: 26476407 DOI: 10.1093/hmg/ddv437] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
505 König J, Wells J, Cani PD, García-Ródenas CL, MacDonald T, Mercenier A, Whyte J, Troost F, Brummer RJ. Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol 2016;7:e196. [PMID: 27763627 DOI: 10.1038/ctg.2016.54] [Cited by in Crossref: 318] [Cited by in F6Publishing: 299] [Article Influence: 53.0] [Reference Citation Analysis]
506 Meddens CA, Harakalova M, van den Dungen NA, Foroughi Asl H, Hijma HJ, Cuppen EP, Björkegren JL, Asselbergs FW, Nieuwenhuis EE, Mokry M. Systematic analysis of chromatin interactions at disease associated loci links novel candidate genes to inflammatory bowel disease. Genome Biol 2016;17:247. [PMID: 27903283 DOI: 10.1186/s13059-016-1100-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
507 Naing A, Papadopoulos KP, Autio KA, Ott PA, Patel MR, Wong DJ, Falchook GS, Pant S, Whiteside M, Rasco DR, Mumm JB, Chan IH, Bendell JC, Bauer TM, Colen RR, Hong DS, Van Vlasselaer P, Tannir NM, Oft M, Infante JR. Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors. J Clin Oncol 2016;34:3562-9. [PMID: 27528724 DOI: 10.1200/JCO.2016.68.1106] [Cited by in Crossref: 101] [Cited by in F6Publishing: 58] [Article Influence: 20.2] [Reference Citation Analysis]
508 Kelsen JR, Dawany N, Martinez A, Grochowski CM, Maurer K, Rappaport E, Piccoli DA, Baldassano RN, Mamula P, Sullivan KE, Devoto M. A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report. BMC Gastroenterol 2015;15:160. [PMID: 26581487 DOI: 10.1186/s12876-015-0394-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
509 Wang B, Lim JH, Kajikawa T, Li X, Vallance BA, Moutsopoulos NM, Chavakis T, Hajishengallis G. Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis. Cell Rep 2019;26:1614-1626.e5. [PMID: 30726742 DOI: 10.1016/j.celrep.2019.01.054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
510 Cuchet-Lourenço D, Eletto D, Wu C, Plagnol V, Papapietro O, Curtis J, Ceron-Gutierrez L, Bacon CM, Hackett S, Alsaleem B, Maes M, Gaspar M, Alisaac A, Goss E, AlIdrissi E, Siegmund D, Wajant H, Kumararatne D, AlZahrani MS, Arkwright PD, Abinun M, Doffinger R, Nejentsev S. Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science 2018;361:810-3. [PMID: 30026316 DOI: 10.1126/science.aar2641] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 24.0] [Reference Citation Analysis]
511 Bain CC, Mowat AM. Macrophages in intestinal homeostasis and inflammation. Immunol Rev. 2014;260:102-117. [PMID: 24942685 DOI: 10.1111/imr.12192] [Cited by in Crossref: 289] [Cited by in F6Publishing: 274] [Article Influence: 41.3] [Reference Citation Analysis]
512 Basso PJ, Fonseca MT, Bonfá G, Alves VB, Sales-Campos H, Nardini V, Cardoso CR. Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease. Braz J Med Biol Res 2014;47:727-37. [PMID: 25075576 DOI: 10.1590/1414-431x20143932] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
513 Padua D, Vu JP, Germano PM, Pisegna JR. The Role of Neuropeptides in Mouse Models of Colitis. J Mol Neurosci. 2016;59:203-210. [PMID: 26646243 DOI: 10.1007/s12031-015-0688-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
514 Kidess E, Kleerebezem M, Brugman S. Colonizing Microbes, IL-10 and IL-22: Keeping the Peace at the Mucosal Surface. Front Microbiol 2021;12:729053. [PMID: 34603258 DOI: 10.3389/fmicb.2021.729053] [Reference Citation Analysis]
515 Shouval DS, Ouahed J, Biswas A, Goettel JA, Horwitz BH, Klein C, Muise AM, Snapper SB. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. Adv Immunol 2014;122:177-210. [PMID: 24507158 DOI: 10.1016/B978-0-12-800267-4.00005-5] [Cited by in Crossref: 159] [Cited by in F6Publishing: 106] [Article Influence: 19.9] [Reference Citation Analysis]
516 Oh SH, Kim KM. Current issues of pediatric inflammatory bowel disease in Korea. Korean J Pediatr. 2014;57:465-471. [PMID: 25550700 DOI: 10.3345/kjp.2014.57.11.465] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
517 Shigemori S, Shimosato T. Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases. Front Immunol 2017;8:22. [PMID: 28179904 DOI: 10.3389/fimmu.2017.00022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
518 Nakouzi G, Kreidieh K, Yazbek S. A review of the diverse genetic disorders in the Lebanese population: highlighting the urgency for community genetic services. J Community Genet 2015;6:83-105. [PMID: 25261319 DOI: 10.1007/s12687-014-0203-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
519 Papoutsopoulou S, Pollock L, Walker C, Tench W, Samad SS, Bergey F, Lenzi L, Sheibani-Tezerji R, Rosenstiel P, Alam MT, Martins Dos Santos VAP, Müller W, Campbell BJ. Impact of Interleukin 10 Deficiency on Intestinal Epithelium Responses to Inflammatory Signals. Front Immunol 2021;12:690817. [PMID: 34220850 DOI: 10.3389/fimmu.2021.690817] [Reference Citation Analysis]
520 Kotlarz D, Ziętara N, Uzel G, Weidemann T, Braun CJ, Diestelhorst J, Krawitz PM, Robinson PN, Hecht J, Puchałka J, Gertz EM, Schäffer AA, Lawrence MG, Kardava L, Pfeifer D, Baumann U, Pfister ED, Hanson EP, Schambach A, Jacobs R, Kreipe H, Moir S, Milner JD, Schwille P, Mundlos S, Klein C. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med 2013;210:433-43. [PMID: 23440042 DOI: 10.1084/jem.20111229] [Cited by in Crossref: 140] [Cited by in F6Publishing: 122] [Article Influence: 15.6] [Reference Citation Analysis]
521 Gjymishka A, Coman RM, Brusko TM, Glover SC. Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. Immunotherapy. 2013;5:1357-1366. [PMID: 24283846 DOI: 10.2217/imt.13.130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
522 Witkowski M, Witkowski M, Gagliani N, Huber S. Recipe for IBD: can we use food to control inflammatory bowel disease? Semin Immunopathol 2018;40:145-56. [PMID: 29124320 DOI: 10.1007/s00281-017-0658-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
523 Ye BD, McGovern DP. Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility. Expert Rev Clin Immunol 2016;12:1091-107. [PMID: 27156530 DOI: 10.1080/1744666X.2016.1184972] [Cited by in Crossref: 45] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
524 Standing A, Omoyinmi E, Brogan P. Gene hunting in autoinflammation. Clin Transl Allergy 2013;3:32. [PMID: 24070009 DOI: 10.1186/2045-7022-3-32] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
525 Schmitt H, Neufert C, Neurath MF, Atreya R. Resolution of Crohn's disease. Semin Immunopathol 2019;41:737-46. [PMID: 31552470 DOI: 10.1007/s00281-019-00756-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
526 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Reference Citation Analysis]
527 Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML, Kastner DL, Holland SM. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum. 2012;64:2022-2027. [PMID: 22161697 DOI: 10.1002/art.34332] [Cited by in Crossref: 123] [Cited by in F6Publishing: 95] [Article Influence: 11.2] [Reference Citation Analysis]
528 Biswas A, Shouval DS, Griffith A, Goettel JA, Field M, Kang YH, Konnikova L, Janssen E, Redhu NS, Thrasher AJ, Chatila T, Kuchroo VK, Geha RS, Notarangelo LD, Pai SY, Horwitz BH, Snapper SB. WASP-mediated regulation of anti-inflammatory macrophages is IL-10 dependent and is critical for intestinal homeostasis. Nat Commun 2018;9:1779. [PMID: 29725003 DOI: 10.1038/s41467-018-03670-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
529 de Souza HSP, Fiocchi C, Iliopoulos D. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14:739-749. [PMID: 28831186 DOI: 10.1038/nrgastro.2017.110] [Cited by in Crossref: 151] [Cited by in F6Publishing: 134] [Article Influence: 30.2] [Reference Citation Analysis]
530 Morhardt TL, Hayashi A, Ochi T, Quirós M, Kitamoto S, Nagao-Kitamoto H, Kuffa P, Atarashi K, Honda K, Kao JY, Nusrat A, Kamada N. IL-10 produced by macrophages regulates epithelial integrity in the small intestine. Sci Rep 2019;9:1223. [PMID: 30718924 DOI: 10.1038/s41598-018-38125-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
531 Haas OA. Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework. Front Immunol 2018;9:3136. [PMID: 30809233 DOI: 10.3389/fimmu.2018.03136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
532 Wittmann Dayagi T, Werner L, Pinsker M, Salamon N, Barschak I, Weiss B, Shouval DS. Mucosal IL-10 and IL-10 receptor expression patterns in paediatric patients with ulcerative colitis. Int J Exp Pathol 2021;102:4-10. [PMID: 33405352 DOI: 10.1111/iep.12382] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
533 Blumberg RS. Environment and Genes: What Is the Interaction? Dig Dis 2016;34:20-6. [PMID: 26982321 DOI: 10.1159/000442920] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
534 Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13. [PMID: 24669294 DOI: 10.12703/p6-13] [Cited by in Crossref: 2181] [Cited by in F6Publishing: 1481] [Article Influence: 272.6] [Reference Citation Analysis]
535 Liu B, Tonkonogy SL, Sartor RB. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology. 2011;141:653-662, 662.e1-4. [PMID: 21679711 DOI: 10.1053/j.gastro.2011.04.053.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
536 Sanctuary MR, Huang RH, Jones AA, Luck ME, Aherne CM, Jedlicka P, de Zoeten EF, Collins CB. miR-106a deficiency attenuates inflammation in murine IBD models. Mucosal Immunol 2019;12:200-11. [PMID: 30327532 DOI: 10.1038/s41385-018-0091-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
537 Gu QP, Bai AP. Interleukin-10 and inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2011; 19(1): 57-61 [DOI: 10.11569/wcjd.v19.i1.57] [Reference Citation Analysis]
538 Dzidic M, Boix-Amorós A, Selma-Royo M, Mira A, Collado MC. Gut Microbiota and Mucosal Immunity in the Neonate. Med Sci (Basel) 2018;6:E56. [PMID: 30018263 DOI: 10.3390/medsci6030056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
539 Chen S, Wu X, Yu Z. Juglone Suppresses Inflammation and Oxidative Stress in Colitis Mice. Front Immunol 2021;12:674341. [PMID: 34421890 DOI: 10.3389/fimmu.2021.674341] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
540 Koukouikila-Koussounda F, Ntoumi F, Ndounga M, Tong HV, Abena AA, Velavan TP. Genetic evidence of regulatory gene variants of the STAT6, IL10R and FOXP3 locus as a susceptibility factor in uncomplicated malaria and parasitaemia in Congolese children. Malar J 2013;12:9. [PMID: 23297791 DOI: 10.1186/1475-2875-12-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
541 Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol. 2020;17:597-617. [PMID: 32710014 DOI: 10.1038/s41575-020-0331-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
542 Smallie T, Ricchetti G, Horwood NJ, Feldmann M, Clark AR, Williams LM. IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages. J Exp Med 2010;207:2081-8. [PMID: 20805562 DOI: 10.1084/jem.20100414] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 6.4] [Reference Citation Analysis]
543 Cardoso A, Gil Castro A, Martins AC, Carriche GM, Murigneux V, Castro I, Cumano A, Vieira P, Saraiva M. The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis. Front Immunol 2018;9:400. [PMID: 29545807 DOI: 10.3389/fimmu.2018.00400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
544 Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1772-1788. [PMID: 23656897 DOI: 10.1097/mib.0b013e318281f5a3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 56] [Article Influence: 11.5] [Reference Citation Analysis]
545 Dubé PE, Yan F, Punit S, Girish N, McElroy SJ, Washington MK, Polk DB. Epidermal growth factor receptor inhibits colitis-associated cancer in mice. J Clin Invest. 2012;122:2780-2792. [PMID: 22772467 DOI: 10.1172/jci62888] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
546 Lee JJ, Rothenberg ME, Seeley ES, Zimdahl B, Kawano S, Lu WJ, Shin K, Sakata-Kato T, Chen JK, Diehn M, Clarke MF, Beachy PA. Control of inflammation by stromal Hedgehog pathway activation restrains colitis. Proc Natl Acad Sci U S A 2016;113:E7545-53. [PMID: 27815529 DOI: 10.1073/pnas.1616447113] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
547 Mizoguchi A, Mizoguchi E. Animal models of IBD: linkage to human disease. Curr Opin Pharmacol 2010;10:578-87. [PMID: 20860919 DOI: 10.1016/j.coph.2010.05.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
548 Kelsen JR, Baldassano RN, Artis D, Sonnenberg GF. Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol 2015;1:462-76. [PMID: 26393237 DOI: 10.1016/j.jcmgh.2015.06.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
549 Suzuki T, Sasahara Y, Kikuchi A, Kakuta H, Kashiwabara T, Ishige T, Nakayama Y, Tanaka M, Hoshino A, Kanegane H. Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study. J Clin Immunol. 2017;37:67-79. [PMID: 27747465 DOI: 10.1007/s10875-016-0339-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
550 Ziogas DC, Karagiannis AK, Geiger BM, Gras-Miralles B, Najarian R, Reizes O, Fitzpatrick LR, Kokkotou E. Inflammation-induced functional connectivity of melanin-concentrating hormone and IL-10. Peptides 2014;55:58-64. [PMID: 24556508 DOI: 10.1016/j.peptides.2014.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
551 Xue AJ, Miao SJ, Sun H, Qiu XX, Wang SN, Wang L, Ye ZQ, Zheng CF, Huang ZH, Wang YH, Huang Y. Intestinal dysbiosis in pediatric Crohn's disease patients with IL10RA mutations. World J Gastroenterol 2020; 26(22): 3098-3109 [PMID: 32587451 DOI: 10.3748/wjg.v26.i22.3098] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
552 Petschow BW, Burnett BP, Shaw AL, Weaver EM, Klein GL. Dietary requirement for serum-derived bovine immunoglobulins in the clinical management of patients with enteropathy. Dig Dis Sci 2015;60:13-23. [PMID: 25142170 DOI: 10.1007/s10620-014-3322-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]